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One in four people will develop symptomatic hip osteoarthritis during their lifetime and one 
in two symptomatic knee osteoarthritis.1,2 End stage osteoarthritis can be successfully treated 
surgically with Total Knee Arthroplasty and Total Hip Arthroplasty. Pain reduction as well as the 
vast improvement in health related quality-of-life have resulted in a widespread application of 
these procedures.3 Worldwide several hundred thousands Total Knee Prostheses (TKP) and Total 
hip Prostheses (THP) are implanted each year and this number is expected to increase by a factor 
two to six within the next decades.4,5 
Although TKP and THP are generally very successful6, on average 5 to 10 percent of the patients 
require revision surgery 10 years after their TKP or THP.7-10 Revision surgery is an extensive 
procedure with more blood loss than primary TKP and THP and increased risk of a re-revision.9 
Additionally, increased age, hypovolemia during surgery and administration of large amounts 
of fluids intra- and post-operatively are risk factors for multiorgan failure in these patients.11 
Considering this perioperatieve morbidity and mortality rates, it is paramount to monitor the 
safety and quality of TKP and THP before they are freely implanted in patients in order to prevent 
not only unneeded harm to patients but also increased costs to society (i.e. increase of the future 
revision burden). 
At present, most new TKP and THP designs are approved and distributed on the market without 
extensive safety and effectiveness testing via the 510(k) pathway in the US and regulation via 
notified bodies in Europe (Directive 93/42/EEC) .12,13 In 2007 the European Union reclassified total 
hip, total knee and total shoulder prostheses to “class III medical devices” (Directive 2005/50/
EC). Class III medical devices are high risk devices that require pre-marketing testing in patients.14 
Nevertheless, the 510(k) pathway in the US and the reviews of device reliability via notified bodies 
in Europe have created an environment in which unsafe TKP and THP can reach the market.15 This 
lack of adequate regulation has lead to the widespread use of potentially unsafe TKP and THP 
with failure rates 2 to 10 times the standard of national joint registries (5% failures at 10 years 
follow-up), see Figure 1.1.13,16-22 Furthermore problems with fixation methods such as Boneloc 
cement have resulted in revision rates that were 14 times higher than normal.23 
To ensure quality of orthopaedic implants and thus patient safety a phased evidence-based 
introduction, as is common for pharmaceuticals, is needed to regulate the introduction of new 
TKP and THP to the market.24-26 This should include systematic assessment and early detection 
of the major cause of TKP and THP failure, which is aseptic loosening necessitating revision 
surgery.7-10 Loosening starts with sub-millimeter (mm) migration of the prosthesis components 
relative to the bone and gradually evolves into gross movement accompanied by clinical symptoms 
such as pain.27,28 It may take as long as 10 years before the final stages of gross loosening are 








































12  |  Chapter 1
as one to two year postoperatively with Roentgen Stereophotogrammetric Analysis (RSA), an 
X-ray technique.27-29
Figure 1.1: Graph showing the revision rate of TKP in percentage for registries (national average) and three 
unsafe TKP.
RSA
The history of roentgen stereophotogrammetry (RSA) dates back to the time when X-rays 
were discovered, when Davidson and Hedley determined the 3-D position of a pin that was 
radiographed on the same radiograph by two separate x-ray sources.30 In 1972 Selvik, a Swedish 
mathematician and anatomist, developed a roentgen stereophotogrammetry system, which he 
later called roentgen stereophotogrammetric analysis (RSA).29 Modern RSA systems are based on 
this RSA system from Selvik.31 At the same time Kees Spoor, a biomechanical engineer developed 
RSA at the anatomy department (section Biomechanics) at the Leiden University.32
RSA is a highly accurate stereo X-ray technique for assessing three-dimensional (3-D) movement 
between two rigid bodies, i.e. migration of prostheses relative to the bone.29 
The accuracy for measuring prosthetic translations (along the x,y,z axes) is between 0.2 and 
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1
conventional radiographs, which have an accuracy between 5 and 12 mm for translations, the 
accuracy of RSA is 10-20 fold better.39 
In order to measure the migration markers are needed on the prostheses and in the bone. These 
markers have to be visible on radiographs. Furthermore they need to be both chemically and 
biologically inert. For these reasons they are made of tantalum (a metal with atomic number 
73).40,41 The bone markers are inserted into the bone during surgery. The prostheses markers are 
attached to the prosthesis by the manufacturer. This is referred to as marker-based RSA. However, 
marking prostheses creates problems with the planning and execution of the study: increased 
cost of implants, prolonged start-up period and over projection of markers by the implant itself.42 
Furthermore marking the prosthesis may jeopardize its strength and the markers could also act as 
local stress raisers in the bone cement resulting in cement cracks, which could lead to loosening. 
In order to overcome these problems caused by prosthesis markers, a method was developed that 
does not require any markers on the prostheses: model-based RSA (MB-RSA).42,43 MB-RSA uses 
CAD models or models from reversed engineering instead of markers on the prosthesis. These 
3-D surface models are “matched” on the radiographs by minimizing the difference between 
the virtual projection of the model with the actual projection of the prosthesis as is appears in a 
radiograph.42,43
The RSA set-up consists of two synchronized X-ray tubes, angled 20 degrees to the vertical and 
positioned approximately 1.5 meters above the X-ray sensor, see Figure 1.2. Generally, the first 
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Figure 1.2 (designed by Bin Zhang): Top image: schematic drawing of the RSA set-up including patient 
position, table, calibration and the rontgen foci. The radiographic film/detector (not shown) are positioned 
under the calibration box. At the lower surface of the calibration box fiducial markers are attached and at 
the upper surface control markers are attached. These markers are positioned with a computer controlled 
device and the position of these markers is known within a few micrometers allowing an in vivo accuracy of 
the entire system of 0.2mm for translations and 0.5 degrees for rotations. Lower left image: (model based) 
RSA analysis with fiducial markers (yellow), control markers (green), bone markers (red) and prosthesis visisble 
on the left and right rontgen image. Lower right image: final 3-D migration results presented in graphs for 
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Early migration and late revision for aseptic loosening
The relation between short-term RSA results and future loosening of TKP and THP has been 
described in detail by Grewal44, Ryd27, Kärrholm28, Nieuwenhuijse45 and Hauptfleisch22. Grewal 
et al. studied three types of TKP and found that increased migration of the tibial component 
at 1 year was associated with increased revision rates for aseptic loosening at 5 years.44 Ryd 
et al. studied 158 tibial components in TKA with a maximum follow-up of 10 years. Fifteen 
implants were revised for mechanical loosening. After one year follow-up, these implants had a 
significantly larger migration rate than the non-revised implants but were asymptomatic at that 
time.27 
Kärrholm et al. found the same correlation in a study of 84 hip stems. After a period of five to 
eight years, 62 stems were still in situ while nine had been revised. The revised components 
exhibited significantly higher migration after two year.28 Nieuwenhuijse et al. demonstrated the 
predictive value of RSA for future aseptic loosening in a study of 41 Exeter cups.45 Hauptfleisch 
et al. confirmed the high revision rate of the Charnley Elite femoral stem.22 This was predicted 
in their previous RSA study in which the Charnley Elite stem showed more rapid posterior head 
migration in the 1st year and the 2nd year than the Exeter stem.22,46
Although very promising, the evidence for the relation between early migration and late failure 
of TKP and THP by aseptic loosening, is limited to the TKP and THP used in the small number of 
studies mentioned above.22,27,28,44 To ensure wide applicability of migration results further studies 
are needed that reflect the diversity in TKP and THP designs and fixation methods.
Aim of this thesis
The aim of this thesis is to evaluate the clinical value of migration measured with RSA for future 
aseptic loosening of new total knee (TKP) and total hip prostheses (THP) in the context of a 
phased introduction and as part of post-marketing surveillance.
Chapter 2 explores the proof of concept that early identification of potentially unsafe TKP and 
THP with RSA results in lower overall revision rates in the National Joint Registers.
Chapter 3 is a systematic review on the prediction of early migration of one type of TKP, based 
on the results of a the previous RSA trial at our institution and whether the results are applicable 









































16  |  Chapter 1
Chapter 4 evaluates the effect of three types of fixation (uncoated, hydroxyapatite coated and 
cemented) on the long term migration of tibial components.
Chapter 5 compares the long term migration of tibial components between mobile bearing TKP 
and fixed bearing TKP and measures the wear underneath the mobile bearing in vivo.
Chapter 6 reports on the development of a quality assessment checklist for articles, the AQUILA 
checklists for reporting quality, methodological quality and generalizability for case series and 
cohorts in total hip and total knee arthroplasty. These checklists are used in chapters 7 and 8.
Chapter 7 is a systematic review on the association between early migration and late aseptic 
revision for the tibial component in TKP. 
Chapter 8 is a systematic review on the association between early migration and late aseptic 
revision for the acetabular component in THP.
Chapter 9 elaborates on the methodological considerations of chapter 7 and 8 and also provides 
a worked example of the analyses of chapter 7 and 8.
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Abstract
Although the overall survival of knee and hip prostheses at ten years averages 90%, recent 
problems with several hip and knee prostheses have illustrated that the orthopaedic community, 
industry, and regulators can still further improve patient safety. Given the early predictive properties 
of roentgen stereophotogrammetric analysis (RSA) and the meticulous follow-up of national joint 
registries, these two methods are ideal tools for such a phased clinical introduction. In this paper, 
we elaborate on the predictive power of RSA within a two-year follow-up after arthroplasty and 
its relationship to national joint registries. The association between RSA prosthesis-migration data 
and registry data is evaluated.
The five-year rate of revision of RSA-tested total knee replacements was compared with that of 
non-RSA-tested total knee replacements. Data were extracted from the published results of the 
national joint registries of Sweden, Australia, and New Zealand.
There was a 22% to 35% reduction in the number of revisions of RSA-tested total knee 
replacements as compared with non-RSA-tested total knee replacements in the national joint 
registries. Assuming that the total cost of total knee arthroplasty is $37,000 in the United States, 
a 22% to 35% reduction in the number of revisions (currently close to 55,000 annually) could 
lead to an estimated annual savings of over $400 million to the health-care system.
The phased clinical introduction of new prostheses with two-year RSA results as a qualitative tool 
could lead to better patient care and could reduce the costs associated with revision total knee 
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Introduction
The clinical introduction of new prosthetic designs by the orthopaedic industry has been compared 
with the introduction of new clothing designs by the fashion industry1,2. New prostheses with 
fashionable design features, such as a matte instead of a polished surface on the Exeter hip stem 
(Exeter, Exeter, United Kingdom), have been launched to the market without extensive clinical 
testing. Under the promise of theoretically superior clinical performance, such prostheses were 
chosen over very satisfactory standard prostheses with outstanding long-term implant survival 
records3,4.
In 1991, the Capital hip (3M Health Care Ltd, Londonborough, United Kingdom) was introduced 
in the United Kingdom as a low-cost total hip replacement. Within six years, almost 5000 patients 
in ninety-five different centers were managed with a Capital hip. With a failure rate of 20% at 
five years, the use of this implant turned out to be disastrous2,5.
However, such disasters do not stop at implant design features. Another disaster was the 
introduction of Boneloc cement (Polymers Reconstructive, Farum, Denmark) in the early 1990s. 
The cement was designed to have a lower curing temperature and a decreased release of toxic 
monomers. Theoretically, this would lead to a decrease in the incidence of aseptic loosening of 
prostheses. However, quite the opposite happened: the incidence of loosening of hip prostheses 
that were fixed with Boneloc cement was up to fourteen times higher in comparison with 
conventional cement6. After the first signs of clinical failure emerged, a small-scale randomized 
clinical roentgen stereophotogrammetric analysis (RSA) study involving fourteen patients who 
were managed with Boneloc cement and fifteen patients who were managed with Palacos 
cement was initiated7. Within one-half year, the migration of both the femoral and acetabular 
components was substantially increased in the patients managed with Boneloc cement. 
Furthermore, no tendency toward stabilization was seen and progressive continuous implant 
migration was present.
One would expect that these disasters could not happen today. However, in general, the 
introduction of new prostheses is still done in almost the same way as it was twenty years ago. 
Although Malchau proposed a much more controlled introduction of new prostheses in 19958, 
recent problems with the ProxiLock hip (Stratec Medical, Oberdorf, Switzerland)9, ASR hip (DePuy, 
Warsaw, Indiana)10,11, Accord knee (DePuy International Ltd., Leeds, United Kingdom)12, and St. 
Leger knee (Covision, Carlton in Lindrick, United Kingdom)13 are examples of situations in which 
the orthopaedic community, industry, and regulators can further improve patient safety.
There has been an upgrade in regulatory classification of hip, knee, and shoulder joint 
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Drug Administration (US FDA). This was important but, as hip and knee prostheses generally have 
a long survival, a difference between a ten-year survival of 95% and one of 80% will be detected 
only after years of follow-up involving a considerable number of patients14. Early detection might 
expose far fewer patients within a period of one or two years.
Most orthopaedic surgeons and decision-makers with a clinical background know and understand 
the concept of preclinical tests, randomized clinical studies, and registries. But what is the concept 
of RSA, and why can it play an important role in the phased introduction of new prostheses or 
related developments?
RSA is a highly accurate stereoradiographic technique for assessing the three-dimensional 
migration of prostheses. The accuracy of RSA for the measurement of prosthetic translations is 
between 0.2 and 0.3 mm, and the accuracy for the measurement of rotations is between 0.2° 
and 1.2°. The accuracy of RSA is ten to twenty times better than that of conventional radiographs. 
RSA provides highly detailed insight into the migration behavior of prostheses in the short term 
(i.e., one to two years) and with relatively small patient cohorts (i.e., thirty to forty patients)15.
As the turnover of new prostheses is high, such a fast measurement technique would be beneficial. 
But the question is: are the early migration measurements indicative of future loosening?
Association of RSA Migration Results and Registry Data
It is no coincidence that several research groups that have initiated or are highly active in national 
registries of joint replacement prostheses are also involved in clinical RSA studies as both methods 
prove invaluable in different stages of the quality control of prostheses. For instance, clinical RSA 
originated in Sweden, which was also one of the first countries with a national joint registry. 
Sweden has the lowest national revision rates in the world for both total knee arthroplasty and 
total hip arthroplasty. The performance of RSA studies with follow-up in a national joint registry 
has proved to be highly successful.
Evidence supporting the assumption that early migration is indicative of late failure due to aseptic 
loosening is increasing. The relationship between short-term RSA results and future loosening of 
prostheses was described in detail by Ryd et al.16 and Kärrholm et al.17. Ryd et al. studied 158 
tibial components that were used for total knee arthroplasty and were followed for a maximum 
of ten years16. Fifteen implants were revised because of mechanical loosening. After six months 
of follow-up, these implants had a significantly larger migration rate than the nonrevised implants 
but were asymptomatic at that time. Kärrholm et al. found the same correlation in a study of 
eighty-four hip stems17. After a period of five to eight years, eight stems had been revised. The 
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In 1998, Nelissen et al. demonstrated in a randomized controlled trial that the uncoated, 
uncemented Interax Total Knee (Stryker-Howmedica, Rutherford, New Jersey) migrated 
excessively18. Therefore, this total knee replacement was considered to be at risk for a high rate 
of failure due to aseptic loosening. Recently, this prediction was confirmed in a systematic review, 
which demonstrates that the revision rate for the uncoated Interax total knee replacement 
was more than three times higher than that for the cemented Interax total knee replacement, 
underlining the early predictive value of RSA19.
In a clinical RSA study of the ProxiLock hip stem (Zimmer, Warsaw, Indiana), six of forty-one 
stems showed nonstabilizing migration of up to 4.7 mm of translation and 12.2° of retroversion9. 
Early migration is associated with an increased risk of possible future loosening and revision, 
and therefore the use of this prosthesis was stopped and the manufacturer discontinued its 
production.
These observations on the clinical effect of RSA echo through several of the national joint 
registries. When an RSA study has been performed for a particular total knee replacement, there 
has been a 22% to 35% reduction in the number of revisions compared with that after total knee 
arthroplasty without RSA testing, as shown by data from the registries of Sweden, Australia, and 
New Zealand (Fig. 1)20-22. This phenomenon can be at least partially explained by the fact that 
RSA allows early identification of implants with poor performance. Once identified, such high-risk 
implants may be taken off the market in an early stage, preventing widespread introduction and 
large numbers of subsequent revisions.
Thus, the RSA-tested total knee replacements that are recorded in the registries represent a selection 
of the total knee replacements. They have low expected revision rates for aseptic loosening due 
to good early RSA results. Concomitantly, the use of RSA-tested total knee replacements with 
excessive early migration is discontinued early on and, as such, these prostheses will not be 
recorded in the registries. At the same time, this selection process is amplified by the transparent 
nature of the registries: poor hospital performance and subsequent low hospital ranking due 
to usage of inferiorly performing prostheses can be avoided by usage of prostheses with either 
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Figure 2.1 Revision rates for the national joint registries of Sweden, Australia, and New Zealand for RSA-
tested total knee replacement (RSA +) compared with non-RSA-tested total knee replacement (RSA −), 
expressed in mean five-year revision rates with 95% confidence intervals. The revision rate for RSA-tested 
total knee replacement is significantly lower in all registries.
Cost-Effectiveness of RSA
The 22% to 35% reduction in the number of revision total knee arthroplasties associated with 
the use of with RSA can translate into considerable annual savings. While we did not perform 
any formal cost-effectiveness analyses, even modest reductions in revision arthroplasties can 
lead to substantial cost savings. For example, assuming that the total cost of revision total knee 
arthroplasty in the US is $37,00023, a 22% to 35% reduction in the number of revisions (currently 
approximately 55,000 for total knee arthroplasty24) could lead to an estimated savings of over 
$400 million for the US health-care system. These savings could be even more substantial if 
RSA is used for each new total knee replacement prior to marketing. Future work will clarify the 
percent reduction in revision that can be attributed to RSA alone, but there is good evidence that 
the reduction is substantial. With these crude estimates of reduction in revision, such impressive 
savings will outweigh any concerns that RSA studies may be too expensive to conduct, even 
without taking into account the ethical issue of exposing patients to new, and as such potentially 
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Standardization of RSA
Mandatory RSA studies require that the results of different RSA studies can be compared. Therefore, 
an international RSA group published RSA standardization guidelines in Acta Orthopaedica in 
200527 and a larger consortium with RSA experts from all over the world is now establishing an 
actual ISO (International Organization for Standardization) standard for RSA. This draft of the 
standard is labeled Committee Draft and is currently being reviewed by all member countries. 
The standard is expected to be finalized in 2012. In addition, an international RSA network is 
being established currently. This network is intended to be a platform for improving the quality of 
clinical RSA research by sharing knowledge between research groups with different levels of RSA 
expertise and RSA-related developments.
The Era of Phased Introduction of New Prostheses
As outlined above, the potential of using RSA as a method of early (premarketing) assessment 
of implant performance is substantial. This potential is currently being recognized by various 
regulatory organs on different levels. The NICE (National Institute for Health and Clinical Excellence) 
guidelines of 2000 (United Kingdom) require adequate long-term clinical data for hip prostheses 
and indicate that RSA is a promising technique that may be an alternative for long-term follow-up 
studies28. However, additional proof of its predictive value for future loosening is demanded. The 
Dutch Orthopaedic Association has adopted in its new guidelines for hip prostheses—published 
in the beginning of 201129—that any new hip prosthesis that is being considered for (commercial) 
introduction to the Dutch market has to pass a phased introduction. This phased introduction 
includes mandatory RSA studies even before larger clinical trials can be initiated.
A phased introduction of new implants or related developments has been proposed by several 
authors8,30-32. The stepwise introduction described by Malchau may be the most widely known 
proposal8. This phased introduction consists of the following three steps: (1) preclinical tests, (2) 
large clinical trials (ideally multicenter and randomized), and (3) postmarket surveillance in national 
registries. In this proposal, Malchau acknowledged the potential of RSA and recommended the 
application of RSA follow-up in both Step 1 and Step 28.
In this position statement, we propose to modify this stepwise introduction of new implants or 
related developments by introducing an additional, intermediary step that explicitly requires RSA 
studies after the initial first step of preclinical testing: (1) preclinical tests, (2) two-year clinical RSA 
trials, (3) larger multicenter clinical studies, and (4) postmarket surveillance in national registries. 
In this way, advantage is taken of the great potential of RSA regarding patient protection in the 
introduction of new implants.
Implementation of this phased introduction of new prostheses, with RSA as an early qualitative 
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Abstract
In a previous radiostereometric (RSA) trial the uncoated Interax tibial components had shown 
excessive migration compared to HA-coated and cemented tibial components. It was predicted 
that this type of fixation would have a high failure rate. The purpose of this systematic review and 
meta-analysis is to investigate whether the RSA prediction is correct. 
We performed a systematic review and meta-analysis to determine the revision rate for aseptic 
loosening of the uncoated and cemented Interax tibial components. 
Three studies were included with a total of 349 Interax total knee arthroplasties (TKA) for the 
comparison of uncoated fixation with cement. There were a total of 30 revisions: 27 uncoated 
and 3 cemented components. There was a 3 times higher revision rate of the uncoated Interax 
components compared to cemented Interax components; OR 3 [95% CI 1.4 to 7.2].
The meta-analysis confirms the prediction of a previous RSA trial. The uncoated Interax 
components showed the highest migration and turned out to have the highest revision rate for 
aseptic loosening. RSA appears to enable efficient detection of an inferior design as early as 2 








































RSA prediction of high failure rate for the uncoated Interax TKA confirmed by meta-analysis  |  33
3
Introduction
Aseptic loosening remains a major reason for revision surgery in Total Knee Arthroplasty (TKA).1,2 
Since revision rates are generally low it is necessary to follow up hundreds if not thousands of 
patients for a long period of time (10 years) to be able to detect inferior designs.3 
A method for early detection of aseptic loosening exposing as few patients as possible is 
therefore of value. Radiostereometric analysis (RSA) enables accurate measurement of migration 
of prosthetic components relative to the bone4, which has been shown to be associated with late 
aseptic loosening.5-7
Although these findings are promising and the number for RSA studies is increasing, few studies 
have actually researched whether the RSA predictions are correct.5-8 In TKA the question thus 
remains: Do TKA with increased early migration have higher revision rates for aseptic loosening? 
We have already shown in a randomized RSA trial that uncoated Interax tibial components 
have increased early migration compared to HA-coated and cemented tibial components.9 We 
predicted that the uncoated components would have a high failure rate. The aim of the present 
study was therefore to investigate whether this prediction of the previous RSA trial is correct. We 
performed a meta-analysis to evaluate the failure rate of these components.
Methods
Design of the meta-analysis, and rationale
The design is based on the Cochrane standards and reporting of this meta-analysis is according 
to the PRISMA guidelines.10 In order to exclude confounding due to differences in prosthesis 
design, the meta-analysis is restricted to studies comprising exactly the same implant as the 
previously published RSA-trial9: the cruciate retaining (CR) Interax TKA tibial component, 
(Howmedica / Stryker, Rutherford New Jersey) with two polyethylene halfbearings. The fixation 
of the components is either by cement or by bone ingrowth on uncoated or hydroxy-apatite (HA) 
coated prosthetic surfaces. The cemented components had a diamond surface on the side that 
was within bone, whereas the uncemented components had a mesh-wire surface (2.25 square 
millimetres corresponding to circular pore diameter of 1690 micrometers) with or without a HA 
coating.
The outcome of interest is the number of revisions or recommended revisions for aseptic loosening 
of the tibial component, for each fixation separately. This outcome will be compared to the early 
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tibial component compared to the cemented and HA coated tibial components (Figure 3.1). 
Uncemented components show high initial migration followed by stabilisation.11-16 Thus, we also 
present the migration rate of MTPM (mm/year) determined on the migration measured with the 
post-operative RSA examination as reference (Table 3.1). 
Figure 3.1 Summary of the migration results of the previous RSA trial.9 The plot shows the mean migration 
– expressed as Maximal Total Point Motion (MTPM) - with 95% CI for each type of fixation of the tibial 
components: red dashed line for uncoated; green dotted line for HA-coated and blue solid line for cement. 
The uncoated tibial components showed the most migration. * mm = millimetre
Literature search
The literature search is the foundation on which a systematic review and meta-analysis is built. 
Inadequate search strategies have been shown to give biased results.17 We therefore adopted 
a thorough search strategy in collaboration with a medical librarian, JWS. The following 
bibliographies were searched up to and including March 2011: PubMed, EMBASE (OVID version), 
Web of Science, Cochrane Library, Current Contents Connect, CINAHL (Ebscohost-version), 
Academic Search Premier (Ebscohost-version). Additionally, the websites of the following medical 
journal publishers were searched: Elsevier ScienceDirect, WileyBlackwell, Lippincott-Williams 
& Wilkins, Highwire, Informaworld/ Informahealth, and Springer. To reduce the effect of any 
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International Clinical Trials Registry Platform, clincialtrial.gov and the proceedings of the major 
conferences (NOF, AAOS, EFORT, ESSKA, ISTA). Furthermore, the bibliographies of included 
studies were hand searched for relevant publications. Also, various lesser known databases were 
searched, e.g. ScienceGov and OAIster. Finally, Google Scholar was searched.
The search involved among others the all fields- and fulltext-options to screen if the following 
component was mentioned anywhere in a manuscript: “Interax” and relevant abbreviations and 
extensions. Since “Interax” is a registered brand name of a particular TKA model, it was assumed 
to be spelled out the same way in the text of a manuscript irrespective of the language used. We 
did not use any language restrictions
Table 3.1: Mean migration rate of MTPM expressed in mm / year.
Cemented HA-coated Uncoated
Migration Rate* Mean   95%CI Mean   95%CI Mean   95%CI
0   to  6 months 1.22     0.88 - 1.57 1.84    1.07 - 2.61 2.45    1.82 - 3.10
6   to 12 months 0.24    -0.34 - 0.82 0.27    -0.02 - 0.57 0.60    0.06 - 1.15
12 to 24 months -0.12   -0.31 - 0.07 0.03    -0.12 - 0.18   0.19    0.02 - 0.35
* The uncoated components showed the highest migration rate. The migration rate was determined on the 
migration measured with the post-operative RSA examination as reference.
0 to 6 months: Cem vs HA p= 0.16; Cem vs UN p = 0.01; HA vs UN p= 0.15 (GLMM)
Study selection
All studies were subjected to the following inclusion criteria:
1) The study comprises an original patient cohort treated with the Interax TKA (Howmedica, 
Rutherford, New Jersey).
2) The cruciate retaining Interax prosthesis with halfbearings is used (Posterior stabilised 
Interax and Interax ISA versions are excluded).
3) The type of fixation of the tibial component and the number of knees receiving this type 
of fixation is adequately reported.
4) Number of revisions or recommended revision for aseptic loosening of the tibial 
component is reported for each fixation separately.
5) At least two fixation types are compared.
Two reviewers, BGP and MJN, independently subjected all studies to these five inclusion criteria. 
In cases where the title and abstract were inconclusive, the full text article was obtained. Any 








































36  |  Chapter 3
to reach a consensus. Randomized Controlled Trials (RCT) as well as observational studies were 
considered for inclusion.
Quality Assessment and Data extraction
The quality of each included study was independently appraised by two reviewers, BGP and 
MJN, using the Jadad Scale.18 The same reviewers independently extracted relevant data for each 
included study using a standardized form including demographic data, number of TKA in each 
fixation group, number of revisions for aseptic loosening in each fixation group, and loss to follow 
up. Any disagreement between the reviewers was resolved by re-examination and subsequent 
discussion for consensus.
Statistical analysis
Before considering a meta-analysis (pooling of data), we investigated whether it was appropriate 
to pool the data. Studies should be similar in design and patient population. In addition, the 
variability in effect size between studies should not exceed those expected from sampling error: 
low heterogeneity is desirable. Heterogeneity was assessed by calculating the I2-statistic, which 
is appropriate in case of a small number of studies.19 Publication bias was assessed with a funnel 
plot.20 Meta-analysis was performed with Peto Odds Ratio (OR) fixed effect pooling and Mantel-
Haenszel random effects pooling for the risk difference (RD) and number needed to treat (NNT).21 
The NNT was defined as the number of cemented tibial components that would have to be 
implanted in order to prevent 1 revision as compared to when uncoated components were 
implanted. We used RevMan software.
Results
Study selection & study characteristics
The search strategy resulted in 268 unique hits of which 4 studies could be included (Figure 3.2).22-
25 Two papers were published in the English language23,25, one in German24 and one in French22 
(Table 3.2). Three studies compared the cemented component to the uncoated one.22,24,25 One of 
these studies 24 was part of a thesis 26, which we used for more details. One of these studies25 was 
the long term follow-up of the RSA-trial9 and reported 3 revisions (2 uncoated and 1 cemented) 
for aseptic loosening of the tibial component.
Since only one study with 18 TKA 23 compared the HA-coated tibial component to the uncoated 









































RSA prediction of high failure rate for the uncoated Interax TKA confirmed by meta-analysis  |  37
3
Figure 3.2 Flow diagram providing details on study selection. In case the title and abstract were insufficiently 
conclusive, the full text article was obtained.
Table 3.2 Characteristics of included studies
Cemented vs uncoated HA-coated vs uncoated
Study Pijls 2011 Gicquel 2000 Stukenborg 2000 Petersen 2005§
Type RCT RCT OBS RCT
Number TKA 68 96 209 18
females (%) 55 (81) NS (75) 166 (79) 15 (83)
OA (%) 18 (26) NS (97) NS (67) 18 (100)
RA (%) 49 (72) NS (3) NS (26) 0 (0)
Mean age at operation (years) 66 73 68 76
Mean FU (years) 7.6 2.3 6.8 2
Operation period 1993-1998 1993-1995 1991-1994 -
Deaths (%) 28 (42) 6 (6) 39 (19) 1 (5.5)
Lost to FU (%) 1 (1.5) 20* (20) 3 (1.4) 1 (5.5)
Jadad Quality Score** 3 3 1 2
*20 cases were lost to follow-up: 8 cemented cases and 12 uncoated cases
** Maximal attainable score is 3 because the evaluation of revision on the x-ray cannot be blinded. 
§ Since Petersen et al is the only study evaluating HA-coated versus uncoated and includes only 18 patients, 
no meta-analysis could be performed for the HA-coated versus uncoated comparison.
RCT = Randomized Controlled Trial
OBS = Observational Study
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Uncoated versus cemented tibial component
349 TKA compose the meta-analysis of uncoated versus cemented components. There were 
30 revisions of the tibial component for aseptic loosening of which 27 were for the uncoated 
components compared to 3 for the cemented component.
The odds of revision due to aseptic loosening of the uncoated tibial component was 3.1 times 
higher as compared to the cemented tibial component: pooled Odds Ratio (OR) 3.1 [95% CI 1.4 
to 7.2] (Figure 3.3). The pooled risk difference was 7% [95% CI 3% to 12%] in favour of the 
cemented component. The number needed to treat (NNT) was 14 in favour of the cemented 
components [95% CI to 8 to 33]. This means that for every 14 patients treated with a cemented 
Interax tibial component, 1 revision for aseptic loosening is prevented compared to the uncoated 
component.
Figure 3.3 Forest plot summarising the pooled effect size of cemented versus uncoated tibial components. 
As shown there was a significantly 3.1 times higher revision rate for the uncoated Interax tibial components 
compared to the cemented ones. 
Risk of bias within studies
The sequence of randomization as well as concealment of allocation was described and 
appropriate in two studies.22,25 In one study 23 randomization was performed but the method 
and concealment not adequately described and in another study 24 no randomization was 
performed. In the non-randomized study the decision for implanting either a cemented or an 
uncoated uncemented tibial component was made by the surgeon during the operation leading 
to confounding by indication-because cemented components were used for cases with reduced 
bone quality.24 This confounding would lead to a possible underestimation of the revision rate 
of the uncoated uncemented tibial component. Thus, the higher revision rate for the uncoated 
components compared to the cemented ones may have been an underestimation of the true 
revision rate. 
In all studies blinding was a potential source of bias. Since evaluation of X-rays is essential for the 
indication of a revision and the presence or absence of cement cannot be masked on the X-ray, 








































RSA prediction of high failure rate for the uncoated Interax TKA confirmed by meta-analysis  |  39
3
The number of withdrawals and dropouts was adequately described in all studies. The number of 
lost to follow-up (8 cemented and 12 uncoated) was high in study by Gicquel et al(Table 3.2).22 
All three studies which compared cemented versus uncoated components included all patients 
consecutively during study inclusion period and thus reduced the possibility of selection bias.22,24,25
Discussion
Uncoated versus Cemented Components
Our aim was to investigate whether the predictions of a previous Radiostereometric Analysis (RSA)-
trial were correct. Since the uncoated Interax components had shown the highest migration, it 
was predicted that this type of fixation would have a high failure rate.9 The results of the meta-
analysis show a significant 3 times higher revision rate for the uncoated uncemented component 
compared to the cemented tibial component. Thus the prediction of the previous RSA-trial was 
correct: the uncoated tibial components showed the highest migration and had the highest 
revision rate for aseptic loosening. The uncoated tibial components also continued to migrate 
after 1 year, whereas the HA-coated components stabilized after 1 year. This is in accordance with 
a recent report by Wilson et al, who showed that tibial components can give solid fixation despite 
high levels of initial migration.27
In the RSA trial, the high degree of migration of the uncoated uncemented tibial components was 
identified within 2 years in a small group of 44 patients (24 in the cemented group and 20 in the 
non-coated group) compared to the 349 in the meta-analysis. This emphasizes the value of RSA 
for the early detection of inferior TKA designs in a small series of patients.5-7 
It is noteworthy that none of the individual traditional clinical studies with large numbers of 
patients and medium term or long term follow-up reported a significant difference in revision 
rates between the uncoated uncemented and cemented Interax tibial component.22,24 Only when 
the results of these studies were combined in a meta-analysis setting did the high revision rate in 
the uncoated components became clearly visible. 
Uncoated versus HA-coated
One of the selected studies compared the uncoated tibial component to the HA-coated 
component.23 This study involved only 18 patients followed for 2 years. Because of the short 
follow-up and small patient cohort it was not appropriate to perform a meta-analysis for the 
uncoated versus HA-coated components. The uncoated Interax tibial component has been 
withdrawn from the market after the results of the RSA trial were published. Since the HA-
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is expected. Less migration of a HA component compared to the non-coated component for the 
Interax CR has also been demonstrated by Østgaard et al.28 Their migration results were similar 
to those of our RSA trial, despite differences in patient characteristics: all their patients were 
suffering from osteoarthritis, compared to 30% osteoarthritis and 70% rheumatoid arthritis in 
our RSA trial.
Strengths and limitations
Our search strategy was thorough and complete. This is underscored by the fact that we found 
two studies that have been published in non-English literature. Although our research question 
was highly specialized, i.e. fixation of a single type of TKA, we were still able to include three 
studies. This is not uncommon for orthopaedic meta-analysis even in Cochrane reviews.29 
The included studies were of moderate quality mostly due to issues with blinding for the fixation 
method, which is a general problem of any study comparing cemented with uncemented 
components and not specific to the present meta-analysis.
Publication bias generally favours the newly introduced treatment30: the uncoated uncemented 
fixation in this case. Since the studies included in this meta-analysis did not find a positive effect 
for the uncoated components, publication bias was probably not a major factor here. Thus, we 
are confident that our conclusion is correct: the uncoated tibial component of the Interax has a 
higher revision rate for aseptic loosening. 
The I-statistic was 0%, so there was no indication for statistical heterogeneity. Despite differences 
in patient demographics, surgical technique or study design all OR’s are on the same side, 
i.e. showed higher –although not individually significantly – revision rates for the uncoated 
component and this confirms the predictions of the RSA trial.
Future Perspectives
More than a decade ago Liow and Murray 31 and Muirhead-Allwood 32 called for a more evidence-
based evaluation and clinical introduction of (new) prosthetic designs and fixations. Malchau 
33 proposed a phased evidence based introduction of new designs. Recently, a renewed call 
for concrete steps has been made towards such a evidence-based clinical introduction.34,35 A 
disastrous design can be detected early post-operatively in a small group of patients by RSA, which 
therefore has the potential to play an important role in the clinical introduction of new models 
and fixation methods in total knee arthroplasty. For example, in vitro testing machine studies, 
should be followed by two year RSA studies in small cohorts in different institutions worldwide, 
followed by larger comparative studies after which introduction to the market can be started.33 
The latter also involving follow-up in national registries. In this way a more phased prosthesis 
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Abstract
In contrast to early migration, the long-term migration of hydroxyapatite- (HA-) coated tibial 
components in TKA has been scantily reported. This randomized controlled trial investigated the 
long-term migration measured by radiostereometric analysis (RSA) of HA-coated, uncoated, and 
cemented tibial components in TKA.
68 knees were randomized to HA-coated (n = 24), uncoated (n = 20), and cemented (n = 24) 
components. All knees were prospectively followed for 11–16 years, or until death or revision. 
RSA was used to evaluate migration at yearly intervals. Clinical and radiographic evaluation was 
according to the Knee Society system. A generalized linear mixed model (GLMM, adjusted for 
age, sex, diagnosis, revisions, and BMI) was used to take into account the repeated-measurement 
design.
The present study involved 742 RSA analyses. The mean migration at 10 years was 1.66 mm for 
HA, 2.25 mm for uncoated and 0.79 mm for the cemented group (p < 0.001). The reduction of 
migration by HA as compared to uncoated components was most pronounced for subsidence 
and external rotation. 3 tibial components were revised for aseptic loosening (2 uncoated and 
1 cemented), 3 for septic loosening (2 uncoated and 1 cemented), and 1 for instability (HA-
coated). 2 of these cases were revised for secondary loosening after a period of stability: 1 case of 
osteolysis and 1 case of late infection. There were no statistically significant differences between 
the fixation groups regarding clinical or radiographic scores.
HA reduces migration of uncemented tibial components. This beneficial effect lasts for more than 
10 years. Cemented components showed the lowest migration. Longitudinal follow-up of TKA 
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Introduction
The early fixation properties of hydroxyapatite (HA) coatings on prostheses have been extensively 
studied 1. Animal studies have shown that HA may convert fibrous tissue into bone, and that even 
under unstable mechanical conditions HA is capable of inducing bone growth across peri-implant 
gaps 2-4. Additionally, radiostereometric (RSA) studies have shown reduced early migration of HA-
coated tibial components compared to porous coated or non-coated tibial components in total 
knee arthroplasty (TKA) 5-8.
In contrast to early migration, the long-term migration of HA-coated tibial components has been 
scantily reported—as shown by a recent systematic review 9,10. Thus, it is not clear whether the 
early biological fixation of HA-coated tibial components will endure and how the long-term 
migration compares to that of uncoated or cemented tibial components. Moreover, HA-specific 
complications such as delamination of the HA layer and third-body wear caused by HA particles 
have been reported in total hip arthroplasty and are potential problems in the long run 11,12.
We have already shown in a randomized radiostereometric trial of HA-coated, uncoated, and 
cemented tibial fixation that HA significantly reduces early migration compared to uncoated 
components 5. Here, we investigated the long-term (11- to 16-year) migration in these patients.
Methods
Study design and patient demographics
68 consecutive posterior cruciate retaining TKAs (Interax; Howmedica, Rutherford, NJ) performed 
in 48 patients because of osteoarthritis or rheumatoid arthritis, were included in a randomized, 
controlled trial in an academic hospital between 1993 and 1998. The study was done in 
compliance with the Helsinki Declaration and was approved by the institutional ethics committee 
(pp 166/93; November 30, 1993), and patients gave informed consent. 24 TKAs were performed 
with cemented tibial components, 24 with HA-coated tibial components, and 20 with uncoated 
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Table 4.1. Baseline characteristics
Cement (n = 24)
Mean (SD)
HA (n = 24)
Mean (SD)
Uncoated (n = 20)
Mean (SD)
Age 69 (8.6) 63 (11) 65 (15)
Sex (F:M) 18:6 21:3 16:4
Diagnosis (RA:OA:SA) 15:9:0 17:6:1 17:3:0
BMI 26 (3.8) 27 (4.9) 24 (3.3)
Preoperative FTA angle 176 (8.1) 174 (8.7) 171 (12)
Preoperative KSS 27 (11) 22 (17) 25 (21)
Preoperative KSS (function) 14 (18) 14 (21) 5 (11)
RA: rheumatoid arthritis; OA: osteoarthritis; SA: sequelae after septic arthritis.
Reporting was in accordance with the CONSORT guidelines and the RSA guidelines 13,14. 2-year 
migration results and details of patients and methods have been reported previously5.
Fixation of the tibial component with HA was compared to uncoated fixation and to fixation 
with cement. The inserts were made of ultra-high-molecular-weight polyethylene (UHMWPE), 
sterilized by gamma radiation in air, and machined from ram-extruded GUR 415 resin containing 
calcium stearate. 
In the present study, patients were followed for 11–16 years, or until death or revision of the tibial 
component (Figure 4.1). To account for the learning curve with this—at the time—new TKA at 
our institution (1992) and to gain experience with the RSA equipment, the first 12 TKAs were 
not randomized and received cemented fixation. These 12 TKAs were not included as part of the 
study. Nevertheless, RSA analysis was performed in order to exclude potential selection bias for 
the consecutive study. The migration was similar to that of the randomized cemented cases (p 
= 0.3), as analyzed with a generalized linear mixed model. During the study, patients remained 
blind regarding the fixation method. Observers were blinded during the RSA analysis regarding 
the presence or absence of HA coating, so the study was double-blind regarding the type of 
uncemented fixation (HA-coated or uncoated). Since cement is visible on (RSA) radiographs, the 
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Figure 4.1. CONSORT flow chart.
* This patient moved out of the region at 3 years post-operatively, when the tibial component had stabilized 
at 0.64mm MTPM and there were no signs of loosening on the last radiograph.
Surgical technique
All TKAs were performed by two experienced knee surgeons or under their direct supervision, 
and implanted through a standard midline incision and medial parapatellar arthrotomy. 6–8 
tantalum markers were inserted into the tibial metaphysic bone before final implantation of the 
tibial component.
In the cemented group, Palacos bone cement (Schering, Kenilworth, NJ) was used after mechanical 
pulse-lavage of the cut bone surfaces. To allow migration measurements by marker-based RSA, 
three 2-mm Vitallium markers had been attached to the tibial component by the manufacturer.
RSA technique
The RSA technique has been described previously 5. Analysis of the RSA examinations was 
performed with MBRSA 3.2 software (Medis Specials, Leiden, the Netherlands). The marker 
configuration model RSA technique was used for measurement of the pose of a rigid body in 
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2002, the calibration cage was replaced. Accuracy of the RSA set-up prior to 2002, as determined 
by double examination analysis (n = 40), was as follows for the translations expressed in means: 
x-axis 0.00 mm (SD 0.07 mm), y-axis 0.01 mm (SD 0.06 mm), and z-axis –0.02 mm (SD 0.13 
mm) 5,14. From 2002 onwards (n = 44), the accuracy was: x-axis 0.00 mm (SD 0.03 mm), y-axis 
0.01 mm (SD 0.06 mm), and z-axis –0.01 mm (SD 0.08 mm) according to Kaptein et al. 16. These 
values indicate a high level of precision for the measurement of migration of the tibial component 
relative to the bone and absence of any systematic bias.
Weight-bearing and flexion exercises were postponed until after the first RSA radiograph (1–5 
days postoperatively). The patients were evaluated both clinically and by RSA examinations at 
predefined follow-up times (3 weeks, 6 weeks, 3 months, 6 months, and 1 year postoperatively) 
and then on an annual basis.
Primary outcome: measurement of migration with RSA
The first RSA radiograph served as a baseline reference for the migration measurements.
Maximal total point motion (MTPM)—migration of the point on the prosthesis that has moved 
the most—was used to determine whether the groups were different regarding migration. When 
MTPM was different between the groups, translations and rotations along the x-, y-, and z-axis 
were evaluated to determine how they differed.
Most migration occurs in the first postoperative year, followed by either stabilization or continuous 
migration of the tibial components 17. Since MTPM represents the length of a vector, which 
cannot be subjected to regular addition or subtraction, an additional RSA analysis was carried out 
with the 1-year postoperative RSA radiograph as a reference.
Secondary outcome: clinical evaluation
Clinical evaluation was performed according to the Knee Society score (KSS) and Hospital for 
Special Surgery score (HSS) at each follow-up 18.
Secondary outcome: radiographic evaluation
In addition to the RSA radiographs, conventional weight-bearing radiographs were acquired at 
2-, 5-, 10-, and 15-year follow-up and graded according to the Knee Society roentgenographic 
evaluation: femoral-tibial aligment (FTA angle) and also alfa angle (frontal angle of the femoral 
component), beta angle (frontal angle of the tibial component), and delta angle (sagittal angle 
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Statistics
Due to the high degree of accuracy of RSA, 20 TKAs were required for each trial arm—as was 
standard for RSA studies at the time the present study was designed (1992), 20,21. The results 
were analyzed according to the intention-to-treat principle. To take into account the repeated-
measures design of the study, any missing follow-up occasion, variation in duration of follow-up, 
and bilaterality, and also to allow for confounder correction 22, a generalized linear mixed model 
(GLMM) was used (R software version 2.12.0), which is considered to be the primary analysis 
method for this type of clinical study 23. In accordance with recent studies, a log-transformation 
was used for maximal total point motion (MTPM)—migration of the point on the prosthesis that 
has moved the most—because it is not normally distributed 24. Due to multiple primary outcomes 
(translations, rotations), a Holm-Bonferroni correction for multiple testing was performed 25. 
Means are presented until 10 years of follow-up. Afterwards, cases are presented individually. 
95% confidence intervals (CIs) were calculated.
Results
Long-term migration
The migration analysis was composed of 742 RSA analyses using the direct postoperative RSA 
radiograph as reference. Figure 4.1 shows the number of valid RSA examinations for each follow-
up occasion. Figure 4.2 shows the mean migration expressed in MTPM for each fixation group up 
to 10 years postoperatively. Throughout the follow-up period, the uncoated tibial components 
showed mean 0.39 mm (95% CI: 0.16–0.62) more migration than the HA-coated tibial 
components and mean 1.0 mm (CI: 0.82–1.18) more than the cemented tibial components, while 
the HA-coated components migrated mean 0.61 mm (CI: 0.42–0.80) more than the cemented 
components (unadjusted: p < 0.001, GLMM; and adjusted for age, sex, diagnosis, revisions, and 
BMI: p < 0.001, GLMM). The mean migration at 10 years was 1.61 mm for the osteoarthritis 
patients and 1.52 mm for the rheumatoid arthritis patients (p = 0.2, GLMM adjusted for fixation, 
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Figure 4.2. Migration in maximum total point motion (MTPM) (mean and standard deviation) according to the 
duration of follow-up in the hydroxyapatite (HA) group (green dotted line), the uncoated group (red dashed 
line), and the cemented group (blue solid line). The direct postoperative RSA radiograph is the reference. 
The groups differed significantly in migration (p < 0.001, GLMM). Missing values at 4-year follow-up were 
estimated as the mean of the 3-year and 5-year follow-up.
To determine whether migration patterns varied between the groups, the mean translations and 
rotations were determined. The uncoated tibial components showed statistically significantly 
increased subsidence, external rotation, and lateral and anterior translation (in the order of 
clinical relevance). The addition of HA affected migration by decreasing subsidence by mean 0.26 
mm (CI: 0.10–0.42) and external rotation by mean 0.47 degrees (CI: 0.27–0.67) compared to 
uncoated components.
463 RSA analyses composed the migration analysis relative to the first postoperative year (Figure 
4.3). There was a statistically significant difference between the fixation groups regarding 
migration from 1 to 10 years (unadjusted: p < 0.001, GLMM; and p < 0.001, GLMM adjusted for 
age, sex, diagnosis, revisions, and BMI). After 1 year, the cemented tibial components migrated 
0.043 mm/year, the HA-coated tibial components migrated 0.057mm/year, and the uncoated 
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Figure 4.3. Migration from 1 to 10 years in maximum total point motion (MTPM) (mean and standard 
deviation) according to the duration of follow-up in the hydroxyapatite (HA) group (green dotted line), the 
uncoated group (red dashed line), and the cemented group (blue solid line). The 1-year postoperative RSA 
radiograph is the reference. The groups differed significantly in migration (p < 0.001, GLMM). Missing values 
at 4-year follow-up were estimated as the mean of the 3-year and 5-year follow-up.
Migration from 1 to 16 years for individual cases with 10 years or more of RSA follow-up is 
presented in Figure 4.4 according to fixation type: HA-coated (8 cases), uncoated (9 cases), and 
cemented (9 cases). There was 1 knee in the HA-coated group and 1 knee in the uncoated group 
and 1 knee in the cemented group with continuous migration. The patient in the HA-coated 
group and cemented group died with the TKA in situ. The patient in the uncoated group is still 
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Figure 4.4. Migration from 1 to 16 years in maximum total point motion (MTPM) of individual cases with 
10 years of RSA follow-up or more according to the duration of follow-up in the hydroxyapatite (HA) group 
(upper row), the uncoated group (middle row), and cemented group (lower row). The 1-year postoperative 
RSA radiograph was the reference.
Clinical evaluation
At 10 years postoperatively, there was a mean increase in KSS compared to preoperatively (59 (CI: 
54–66)). There were no statistically significant or clinically relevant differences in KSS between the 
fixation types (p = 0.9, GLMM adjusted for age, sex, diagnosis, revisions, and BMI) (Table 4.2).
At 10 years postoperatively, there was a mean increase in KSS function compared to preoperatively 
(33 (CI: 21–46)). There were no statistically significant or clinically relevant differences in KSS 
function between the fixation types (p = 0.4, GLMM adjusted for age, gender, diagnosis, revisions, 
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Table 4.2. Clinical and radiographic results
Cement
Mean; SD; (95% CI)
HA
Mean; SD; (95% CI)
Uncoated
Mean; SD; (95% CI)
Knee scorea 5-year 81; 11; [75-88] 81; 13; [74-88] 83; 5; [80-86]
10-year 81; 15; [71-91] 85; 7; [80-90] 87; 7; [81-92]
Last FUf 76; 18; [68-84] 86; 10; [81-90] 81; 14; [74-87]
Knee function 
scoreb
5-year 69; 21; [55-82] 38; 30; [20-55] 52; 35; [30-75]
10-year 45; 29; [25-65] 46; 33; [23-69] 42; 32; [18-67]
Last FUf 29; 34; [14-44] 29; 32; [15-43] 23; 31; [8-38]
HSSc 5-year 48; 8; [44-53] 46; 11; [40-51] 49; 5; [47-52]
10-year 48; 4; [45-50] 49; 7; [44-53] 47; 5; [43-51]
Last FUf 41; 17; [33-48] 51; 14; [45-57] 41; 14; [33-47]
Flexiond 5-year 109; 16; [100-118] 100; 15; [92-108] 101; 14; [93-110]
10-year 110; 16; [100-120] 103; 13; [93-113] 106; 12; [95-110]
Last FUf 105; 13; [99-111] 106; 12; [101-111] 101; 17; [93-108]
FTA anglee 1-year 176; 2.8; [175-177] 177; 3.4; [176-178] 176; 2.4; [175-177]
5-year 177; 2.3; [175-178] 177; 4.1 [175-179] 177; 2.9; [175;178]
10-year 177; 2.2; [175-178] 178; 4.4; [175-181] 176; 2.8; [174-178]
Alfa angle          1-year 93; 2.6; [92-95] 94; 2.7; [93-95] 94; 3.0; [93-96]
Beta angle         1-year 90; 1.7; [89-90] 88; 3.0; [87-89] 89; 2.0; [88-90]
Delta angle        1-year 88; 3.1; [86-89] 88; 2.8; [87-89] 87; 3.5; [86-89]
a p =0.86, GLMM.
b p = 0.43, GLMM.
c p = 0.64, GLMM.
d p = 0.15, GLMM.
e p = 0.28, GLMM.
f Last FU at mean 9.0 years (range 3 months to 16 years) was calculated using the clinical score at the last 
available FU for each patient.
HSS: Hospital for Special Surgery score; FTA angle: femoral-tibial alignment; alfa angle: frontal angle of the 
femoral component; beta angle: frontal angle of the tibial component; delta angle: sagittal angle of the tibial 
component.
Radiographic evaluation
The FTA angles were similar between the fixation types (p = 0.3, GLMM adjusted for age, sex, 
diagnosis, revisions, and BMI) (Table 4.2). There were no statistically significant or clinically relevant 
differences in alfa, beta, or delta angles between the fixation types. Ten years postoperatively, 
there were 2 partial 2-mm radiolucent lines in the HA group, 1 partial 2-mm radiolucent line in 
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Figure 4.5. Individual migration patterns of the liner exchange and revised cases (with the postoperative 
radiograph as reference). For the insert exchanges, the letters at the top indicate the time of insert exchange 
with blue C for cemented tibial components, green H for HA-coated tibial components, and red U for 
uncoated tibial components. The tibial components remained securely fixed after the exchange of insert.
* Secondary loosening due to osteolysis. Extensive antero-lateral osteolysis was seen on the CT-scan. This was 
confirmed at the revision procedure.
Revisions and exchanges of insert
7 knees were revised: 3 tibial components for aseptic loosening (2 uncoated and 1 cemented), 3 
for septic loosening (2 uncoated and 1 cemented), and 1 for instability (HA-coated). The individual 
migration patterns are shown in Figure 4.5. Of note is 1 case that was revised for secondary 
aseptic loosening after a period of stability. This secondary loosening was due to scalloping 
osteolysis at the tibial component located anterolaterally as identified on CT-scan and during the 
revision procedure. There was 1 case that was revised after late infection. This case also showed 
increasing migration after a stable period. There was 1 case of wound necrosis (cemented tibial 
component) early postoperatively that was treated successfully with surgical debridement and 
antibiotics, so the prosthesis was preserved.
There were 7 PE insert exchanges for wear: 2 in the cemented group, 3 in the HA group, and 2 in 
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exchange (with the numbers available; HA-coated vs. cemented, HR = 1.0, CI: 0.2–6.9; p = 1.0; 
and HA-coated vs. uncoated, HR = 0.6, CI: 0.1–5.6; p = 0.6).
Discussion
We found different long-term migration between the 3 fixation types, with cemented components 
showing the lowest migration. For the uncemented components, HA reduces migration compared 
to the uncoated components and this clinically relevant effect endures beyond 10 years. The 
positive effect of HA was most noticeable in reducing subsidence and external rotation compared 
to the uncoated tibial components.
Negative effects of HA are the risk of HA delamination and third-body wear due to HA particles, 
as demonstrated in total hip arthroplasty 11,12. In the present study, the migration patterns of the 
HA-tibial components were stable at the long-term follow-up, so delamination of the HA coating 
was unlikely for the HA applied which was 60 μm thick and had a crystallinity of more than 
90%. Crystallinity of more than 75% has been shown to provide adequate fixation and bone 
ingrowth 26. The rate of insert exchange in the HA group was comparable to that of the cemented 
and uncoated groups, thus no indication for accelerated third-body wear due to HA particles 
was anticipated. However, larger comparative studies are needed to fully address the potential 
influence of third-body wear by HA particles in TKA.
Early migration appears to predict long-term migration 17,21. Indeed, the increased (early) 
migration in the uncoated group compared to the cemented and HA group has been associated 
with an increased revision rate for the uncoated components 27. There were 2 cases of secondary 
loosening after a period of stability. Since these patterns have not been described before, there 
is a need for long-term RSA studies to further investigate these interesting migration patterns. 
The HA-coated components in our study also showed the well-described migration pattern for 
uncemented tibial components: substantial initial migration followed by stabilization 28-30. 
Compared to the HA-coated tibial components, the uncoated components showed more initial 
migration, which took more time to stabilize. Other RSA studies with follow-up ranging from 1 
to 5 years have found similar results regarding the effect of HA on migration compared to porous 
coated and uncoated tibial components 5-8,30-32. In addition, recent clinical cohort series have 
illustrated that good long-term survival (with any reason for revision as endpoint) of 99% at 10 
years and 98% at 10–15 years of follow-up can be achieved with similar HA-coated, posterior 
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The magnitude of difference in migration from 1 to 10 years was less pronounced than the 
magnitude of difference in migration in the early postoperative period. It is not clear whether the 
differences in migration from 1 to 10 years are clinically relevant.
Knee Society scores and radiolographical outcome were similar in all groups. The high rate of insert 
exchange due to wear for the Interax TKA has been described in the literature and was judged to 
be caused by the type of sterilization of the polyethylene (gamma in air) and inappropriate shift of 
the load center on the tibial component, particularly in the smaller sized non-conforming inserts, 
causing excessive stress on the posteromedial and posterolateral surfaces 35.
The strengths of our study are the long-term follow-up and the blinding for the presence or 
absence of the HA coating for both the patient and the observers. In surgical trials, blinding 
is often an issue 36. An HA coating, however, is ideal for a double-blind design, since it cannot 
be seen on radiographs, so the RSA analyzers and patients were blinded. On the other hand, 
cement is visible on (RSA) radiographs, so the study was only single-blind (patient) regarding 
the comparisons with cement. Nonetheless, migration analysis with RSA is a standardized and 
objective method with low susceptibility to different interpretations 14. The risk of biased results 
for the cemented components is therefore negligible.
We should also note some limitations. Three-quarters of our patients suffered from end-stage 
rheumatoid arthritis. One could question whether the conclusions apply to osteoarthritis. However, 
the migration at 10 years was very similar between OA patients and RA patients (1.61 mm and 
1.52 mm). The long-term migration of HA-coated tibial components compared to cemented 
components has been scantily reported 10. The early migration in our study is comparable to that 
found by Önsten et al. 37, who included only OA patients. At 2 years, their cemented components 
migrated (MTPM) approximately 0.6 mm and their HA components migrated approximately 1.0 
mm. These migrations are similar to our results; OA or RA did not influence the effect of HA on 
long-term migration of the tibial components.
In conclusion, HA reduces migration of uncemented tibial components, which was most 
pronounced in the first postoperative years. The beneficial effect of HA endures beyond 10 years 
and there is no evidence for delamination of the HA layer. Since cemented components showed 
the lowest migration throughout the follow-up and have excellent survival in the registries, 
cement is a safe choice for fixation of the tibial component. Longitudinal follow-up of TKA with 
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Abstract
This single-blinded randomised controlled trial investigated whether one design of mobile-
bearing (MB) total knee replacement (TKR) has any advantage over a fixed-bearing (FB) design 
on long-term fixation as measured by radiostereometry. The amount of wear underneath the 
mobile bearing was also evaluated. A series of 42 knees was randomised to MB or FB tibial 
components with appropriate polyethylene inserts and followed for between ten and 12 years, 
or until the death of the patient. The polyethylene in the MB group was superior in that it 
was gamma-irradiated in inert gas and was calcium-stearate free; the polyethylene in the FB 
group was gamma-irradiated in air and contained calcium stearate. In theory this should be 
advantageous to the wear rate of the MB group. At final follow-up the overall mean migration 
was 0.75 mm (sd 0.76) in the MB group and 0.66 mm (sd 0.4) in the FB group, with the FB group 
demonstrating more posterior tilt and the MB group more internal rotation. In the FB group there 
was one revision for aseptic loosening, but none in the MB group. There were no significant 
differences in clinical or radiological scores. 
For the MB group, the mean linear wear rate on the under-surface was 0.026 mm/year (sd 0.014). 
This was significantly smaller than the wear rate of 0.11 mm/year (sd 0.06) in the MB between 
femur and polyethylene (p < 0.001). Nevertheless, even in a best-case setting the mobile bearings 
of this TKR design had no apparent advantage in terms of fixation over the FB knee prosthesis at 
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Introduction
Mobile-bearing (MB) total knee replacements (TKRs) have greater conformity of the femorotibial 
articulation than fixed-bearing (FB) prostheses. This increase in femorotibial contact area should 
reduce contact stresses at both polyethylene (PE) surfaces and theoretically lead to less PE wear.1,2 
The mobility of the PE liner should at least partially transfer shear forces to the ligaments and 
other soft tissues,3 which would tend to reduce the stress at the bone–cement interface, thereby 
reducing the likelihood of component loosening.1,2
However, the advantages described above remain strictly theoretical. Several recent meta-analyses 
could not demonstrate any clinical or radiological advantage for MB TKRs in short- to medium-
term follow-up.4-7 There are only a few randomised controlled trials with long-term -follow-up 
comparing MB with FB TKR.8-10 Although the advantages of the MB TKR remain to be proved, 
reports on bearing dislocation in some designs and third-body wear underneath the mobile insert 
where it is in contact with the tibial base plate raise some concerns.11
In this study we evaluated the potential long-term advantages of MB TKRs using objective 
outcomes measures, including PE wear and migration measured by radiostereometric analysis 
(RSA). RSA is a radiological technique that can be used to accurately measure three-dimensional 
(3D) migration of the knee prosthesis relative to the bone, with resolutions of 0.2 mm.12
Methods
A total of 33 patients with 42 consecutive primary cemented TKRs were included in a randomised, 
controlled trial at the Leiden University Medical Center, which commenced in 1998. The intention 
was to compare MB and FB TKRs in terms of survival and wear, measured by RSA. All patients 
gave informed consent. We used the CONSORT guidelines and RSA guidelines for reporting 
of the ten- to 12-year results.13,14 Patients were allocated based on a random number table to 
receive either an FB TKR (Interax PS; Stryker-Howmedica, Rutherford, New Jersey) or an MB TKR 
-(Interax Integrated Secure Asymmetric (ISA); Stryker-Howmedica). Bilateral cases were performed 
simultaneously, and randomisation always started with the right knee. The femoral components 
from both designs had identical geometric shapes. The MB design had a greater contact area 
than the FB design owing to higher congruency between the bearing surfaces, both between the 
PE surface and the tibia and between the PE and the femoral component. 
Implant and surgical techniques were identical to those described in the two-year results.15 The 
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unknown until the final evaluation of this study. By this time four liners in the FB group had 
failed at 1.6, 6.5, 8.2 and 11.6 years post-operatively, whereas none in the MB group had failed. 
As the liner failures did not require revision of the tibial or femoral components they remained 
in the migration analyses. The PE in the FB group was GUR 415 gamma sterilised in air and 
contained calcium stearate. It had a mean shelf-life (i.e., interval between time of manufacture 
(data provided by manufacturer) and implantation) of 3.0 years. The PE in the MB group was 
GUR 1050 gamma sterilised in inert gas and free of calcium stearate. The mean shelf-life of the 
MB inserts was 0.9 years. This randomised trial therefore compared a best-case (superior PE) MB 
design with a worst-case (inferior PE) FB design. 
The study was a single-blinded design during the course of which patients remained blinded to 
the type of prosthesis they had received. Surgeons and observers were not blinded, as the type 
of bearing is obvious on radiographs. Inclusion criteria were primary TKR for end-stage osteo-
arthritis (OA) or rheumatoid arthritis (RA). Exclusion criteria were revision TKR and a deformity of 
> 20° in any plane. The two-year results of this trial have been previously reported.15
After randomisation there were 21 prostheses in each group. The groups were similar with regard 
to age, gender, diagnosis, body mass index (BMI), pre-operative limb alignment and function 
(Table 5.1).16





Age (yrs) 64 (SD 11) 66 (SD 14)
Female:Male 18:3 16:5
OA:RA 7:14 6:15
BMI 27 (SD 3.1) 27 (SD 5.4)
FTA angle* (degrees) 178 (SD 8.5) 175 (SD 9.2)
KSS (points) 20 (SD 15) 19 (SD 12)
KSS function (points) 24 (SD 19) 17 (SD 19)
* < 175 degrees is valgus, >175 degrees is varus; OA = Osteoarthritis; RA = Rheumatoid Arthritis; KSS = Knee 
Society Score
Patients were followed prospectively at three and six weeks, three and six months, and then 
annually for ten to 12 years post-operatively. During the course of the study eight patients (11 
TKRs: three MB, eight FB) died of causes unrelated to surgery. For all patients who died it was 
known whether they had undergone a revision or not, and their follow-up has been used until 
time of death at a mean of 5.0 years (2.0 to 8.5). Details of the study flow are depicted according 
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Figure 5.1: CONSORT flow chart of progression through the trial (LFU, lost to -follow-up). 
Clinical and radiological evaluation
Clinical evaluation was performed according to the Knee Society score (KSS)17 at each follow-up. 
In addition to the RSA radiographs, conventional weight-bearing radiographs were acquired at 
six weeks, five years and ten years and graded according to the Knee Society roentgenographic 
evaluation: femorotibial aligment (FTA) angle, as well as α (frontal angle of the femoral 
component), β (frontal angle of the tibial component) and δ angles (sagittal angle of the tibial 
component).18
Measurement of 3D migration
The first RSA radiograph served as a baseline reference for the measurement of migration, which 
was performed to a high degree of accuracy throughout the follow-up period.14 It was determined 
whether the groups were different with regard to long-term migration expressed in maximal total 
point motion (MTPM), which is the length of the translation vector of the point on the prosthesis 
that has moved the most.14 The three-dimensional migration (translations and rotations) of the 
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The RSA setup consists of two synchronised x-ray tubes angled 20° from the vertical and positioned 
1.5 m above the x-ray sensor. The RSA was analysed using MBRSA 3.2 software (Medis Specials, 
Leiden, Netherlands). This enables determination of the relative 3D position of the markers of the 
prosthesis in relation to the bone markers. In situations where fewer than three markers could be 
detected in both images of the RSA radiograph, the Marker Configuration Model RSA technique 
was used to measure the position of a rigid body.19 This technique was used in six TKRs (two FB 
and four MB) to save 23 extra follow-up events. 
As determined by double examination analysis (n = 33), the bias in the system was very small for 
translations (x-axis -0.01 mm, y-axis 0.01 mm and z-axis 0.01 mm) and rotations (x-axis -0.07°, 
y-axis -0.03° and z-axis 0.00°). Accuracy at the 95% confidence level for translations was x-axis 
0.14 mm, y-axis 0.12 mm and z-axis 0.28 mm. For rotations the accuracy was x-axis 0.50°, y-axis 
0.46° and z-axis 0.12°. These values indicate a high level of precision for the measurement of 
migration of the tibial component relative to the bone and the absence of any systematic bias. In 
2002 the calibration cage of our RSA unit was replaced, but this had no effect on the accuracy of 
the measurements (p = 0.72, linear regression). 
Measurement of wear on the undersurface of the mobile bearings 
The amount of wear on the under-surface of the mobile PE inserts at follow-up was measured 
using RSA. Wear was defined as a change in distance in the proximal–distal direction between 
tantalum markers in the PE insert and those in the tibial component. Markers (3) on the tibial 
component provide a reference for migration of the marker model of the PE insert in the proximal 
and distal directions. The markers were inserted from the periphery of the PE in order to prevent 
them becoming detached, a situation that could imitate wear. In order to allow reproducible 
insertion, the tantalum markers were inserted during surgery with drill guides at predefined 
angles and depths.15
Because the PE insert is designed to move only in the transverse plane and not proximally or 
distally, it is possible to define wear as the migration of the PE markers in the distal direction. In 
every case wear followed a linear pattern over time. 
As the MB and FB groups were different regarding the quality of the PE, it is not possible to study 
whether the MB reduces PE wear more than the FB. For this reason it was decided that it was not 
appropriate to determine the linear wear rate in the FB group. 
In the MB group the total linear wear of the PE insert was measured on conventional anteroposterior 
(AP) radiographs as described by Collier et al,20 while using the size of the central stem to correct 
for the magnification caused by diverging X-ray beams. Hide et al21 have shown that this method 
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articulation was defined as the total linear wear minus wear between the PE insert and the tibial 
surface. 
Statistical analysis
Owing to the high degree of accuracy of RSA, 20 TKRs were required for each arm of the trial, 
as was standard for RSA studies at the time this study was designed.22 The results were analysed 
according to the intention-to-treat principle. To take into account the repeated measures design 
of the study, bilateral cases (n = 9), any missing follow-up moments and variations in follow-up 
duration, a generalised linear mixed model (GLMM) was used, which is considered the analytical 
method of choice for this type of clinical study.23 A p-value < 0.05 was considered statistically 
significant. 
Results
Clinical and radiological evaluation
The clinical results are presented in Table 5.2. Post-operatively there was a mean 68 points (63 to 
74) increase in KSS compared with the pre-operative scores. There was no statistically significant 
or clinically relevant difference in the KSS knee score between the two groups (p = 0.85, GLMM). 
Death had no effect on KSS score (p = 0.24, GLMM). Post-operatively there was a mean 44 points 
(34 to 54) increase in KSS function score compared with pre-operatively. There was no statistically 
significant or clinically relevant difference in KSS function between the groups (p = 0.14, GLMM). 
There were also no significant differences in flexion between the groups. 
Table 5.2: Clinical Results presented as means, standard deviation (SD) and 95% confidence interval [95%CI]
Mobile
Mean; SD; [ 95%CI]
Fixed
Mean; SD; [ 95%CI] 
KSS* (points) 5 yr 91; 5; [88-94] 85; 15; [76-94]
10 yr 84; 13; [76-92] 90; 6; [86-95]
Last FU^ 81; 15; [74-88] 82; 17; [75-90]
KSS Function**
(points)
5 yr 73; 30; [59-88] 55; 34; [36-75]
10 yr 63; 28; [46-80] 63; 33; [39-86]
Last FU^ 52; 33; [36-67] 33; 36; [16-50]
Flexion        Last FU^
(degrees)
110; 11; [104-115] 109; 14; [103-115]
* p = 0.85 GLMM
** p = 0.14 GLMM
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The radiological results are presented in Table 5.3. There was no statistically significant or clinically 
relevant difference in FTA angle between the MB and FB groups (p = 0.94, GLMM), and no 
statistically significant or clinically relevant differences in α, β or δ angles. The groups were 
comparable with regard to the incidence of radiolucent lines at ten years’ radiological follow-up. 
Two partial 2 mm radiolucent lines in the MB group, both at the lateral side of the tibial tray, were 
noted and one partial 2 mm radiolucent line in the FB group was observed at the medial side of 
the tibial tray.
Table 5.3: Radiological Results presented as means, standard deviation (SD) and 95% confidence interval 
[95%CI]
Mobile
Mean; SD; [ 95%CI]
Fixed
Mean; SD; [ 95%CI]
FTA angle* (degrees) PO 178; 2.7; [177-179] 178; 2.7; [177-179]
5 yr 178; 2.0; [177-179] 179; 3.3 [177-181]
10 yr 179; 2.7; [177-180] 181; 3.9; [179-184]
Alpha angle (degrees)    PO 94; 2.3; [93-95] 94; 2.8; [93-95]
Beta angle (degrees       PO 87; 2.9; [86-89] 87; 2.5; [86-88]
Delta angle (degrees)     PO 88; 2.2; [87-89] 88; 2.1; [87-89]
* p = 0.94GLMM; < 175 degrees is valgus, >175 degrees is varus
PO =  post-operatively
FTA angle  =  Femoral-Tibial Aligment
Alpha angle  =  Frontal angle of the femoral component
Beta angle  =  Frontal angle of the tibial component
Delta angle  =  Saggital angle of the tibial component 
3D migration
A total of 447 RSA analyses form the migration analysis. At ten years’ follow-up the mean MTPM 
was 0.75 mm (sd 0.76) in the MB group and 0.66 mm (sd 0.4) in the FB group (p = 0.42, GLMM) 
(Figure 5.2). Throughout the follow-up the difference in MTPM between the two groups was 
neither statistically significant nor clinically relevant: MTPM MB – MTPM FB = 0.05 mm (95% 
confidence interval (CI) -0.07 to 0.17). When restricted to patients with OA the difference in 
MTPM was 0.02 mm (95% CI -0.13 to 0.16), and when restricted to RA patients the difference 
was 0.11 mm (95% CI -0.08 to 0.30). In the FB group there were two tibial components with 
continuous migration and none in the MB group. The rates of migration were not different in 
the group of patients who died. The mean translations and rotations are presented in Figure 5.3. 
The FB tibial components showed slightly more lateral translation, subsidence and posterior tilt, 
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Figure 5.2. Graph showing the mean migration in maximum total point motion (MTPM) according to the 
duration of follow-up in the mobile- and fixed-bearing groups. The groups do not differ significantly in MTPM 
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Figure 5.3. Graphs showing the mean translations (upper row) and rotations (lower row) according to the 
duration of follow-up in the mobile- (MB) and fixed-bearing (FB) groups. For reasons of clarity the standard 
deviation (vertical bars) is only presented for two, four, six, eight and ten years’ follow-up. The FB tibial 
components showed statistically significantly more lateral translation, subsidence and posterior tilt. The MB 
tibial components showed statistically significantly more internal rotation. All analyses using generalised linear 
mixed model statistics.
Wear of the mobile bearings
The mean linear wear on the tibial bearing surface of the PE component for the MB group 
was 0.026 mm/year (0.019 to 0.033) (Fig. 5.4). The mean total linear wear rate was 0.14 mm/
year in the MB group (0.11 to 0.17). The mean wear of the PE at the femoral bearing surface 
was 0.11 mm/year (0.08 to 0.14). The mean tibial surface PE wear rate of 0.026 mm/year was 
significantly smaller than the mean wear rate of 0.11 mm/year at the femoral bearing surface (p 
< 0.001). 
Complications
In the MB group there was one case that required revision of all components because of septic 
loosening. None of the bearings dislocated. In the FB group there were two cases that required 
revision of all components, one for aseptic loosening and one for septic loosening. There were 
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subsequent instability in three cases and fracture of the posterior stabilising central post of the 
insert after a fall in one case. Including these four liner failures, there was a total of six revisions in 
the FB group during almost 12 years of follow-up, compared with one revision in the MB group. 
Figure 5.4. Graph showing the mean linear underside wear of the polyethylene mobile-bearing according to 
the duration of follow-up, measured with radio-stereometric analysis. The error bars represent the standard 
deviation
Discussion
The results of this randomised controlled trial using RSA show that the MB had comparable 
migration to the FB during ten to 12 years’ follow-up. Therefore, even in a best-case scenario 
(superior PE in the MB group), the MB design did not yield any apparent advantages in terms 
of long-term fixation compared with the FB design with femoral components of the same 
geometrical shape. A mean difference in MTPM < 0.2 mm is not considered clinically relevant.12,14
There are no studies with long-term RSA follow-up available in the literature for comparison. 
However, studies with two years’ RSA follow-up by Hansson et al24 and Henricson et al25 
also found no difference in MTPM between mobile and fixed bearings. In comparison to the 
previous report by Garling et al,15 who presented the two-year results of this trial, there was 
higher variability in subsidence and AP tilting in the FB group. However, at that time no-one was 
aware of the confounding manufacturing and sterilisation differences in the PE, used in the two 
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migration of the tibial component. This conclusion can no longer be supported. In this updated 
study the FB group showed statistically more posterior tilting than the MB group, but the clinical 
relevance of this finding is unclear. One explanation might be the posterior-stabilised design of 
the FB insert compared with the MB insert. Strain on the post in the FB prosthesis due to contact 
with the femoral component during flexion may have caused posterior tilting. 
In addition, there was statistically more internal rotation of the MB group relative to the bone, 
whereas there was little rotation in the FB group. This finding is surprising, considering that MB 
TKRs are designed to, and indeed have been shown to reduce strain on the proximal tibia.26 
However, not all MB designs are the same. This particular MB design accommodates only guided 
rotation through a curved slot on the underside of the liner with respect to the polished tibial 
tray, and not full freedom to rotate around a central or eccentric tibial tray post. Therefore, the 
seemingly paradoxical outwards rotation in this MB TKR might be due to the friction between the 
curved slot and the metal tibial pivot post. 
The number of revisions in this series was small. These results are in accordance with other 
trials where no difference was found in revision rate at long-term follow-up.8-10 With regard to 
medium-term follow-up, several meta--analyses could not demonstrate a difference in revision 
rates.4-7 Therefore, additional trials of long-term follow-up are needed to investigate whether 
mobile bearings have any advantage over the fixed bearings regarding revision rates. 
The additional articulating surface for MB TKRs may itself be a source of problems. In particular, 
Engh et al27 found pitting, scratching and burnishing on the underside of the PE to be greater 
in mobile than in fixed bearings. However, in vivo we found only a small amount of wear under 
the mobile bearing of 0.3 mm at 11 years’ follow-up, which corresponds to a rate of wear of 
0.026 mm/year. This backside wear rate was significantly smaller than the wear rate of the PE 
between the mobile insert and the femur of 0.11 mm/year (p < 0.001), and is unlikely to be of 
clinical relevance. 
Although this was a small series there were no differences between the MB and FB groups with 
regard to clinical outcomes and radiological parameters. These findings confirm the results of 
several meta-analyses.4-7
The strengths of this study are the randomised design, the objective outcome measures (RSA, 
linear wear), the long-term follow-up, blinding of the patients, and the fact that the femoral 
components of both the mobile- and the fixed-bearing group were identical in geometric shape. 
We were also able to demonstrate that even in a best-case scenario the MB knee prostheses have 
no apparent advantage for long-term fixation or wear over the FB prostheses. 
This study has some limitations. Because the type of bearing is recognisable on radiographs the 
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method with low susceptibility to individual interpretation, so the risk of bias can be considered 
negligible.14
It should be accepted that although the study has sufficient power to delineate RSA differences, 
this is unlikely to be true for the clinical scores. The possibility that the results were affected by 
differences in migration between RA and OA patients should also be considered. A separate 
analysis on the difference in migration between MB and FB restricted to either RA or OA patients 
was carried out and no difference in migration rates between the two cohorts was demonstrable. 
Finally it is accepted there was a serious confounder as the MB inserts were produced in superior 
quality PE that was sterilised in inert gas, unlike the material used in the FB TKRs. 
In conclusion, even in a best-case setting the AP sliding, rotating mobile bearings of the studied 
TKR have no clinically relevant advantage on long term fixation over the studied FB knee prosthesis. 
The backside wear underneath the mobile bearing was small and may not be of clinical relevance. 
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Abstract
In the light of both the importance and large numbers of case series and cohort studies 
(observational studies) in orthopaedic literature, it is remarkable that there is currently no validated 
measurement tool to appraise their quality. A Delphi approach was used to develop a checklist for 
reporting quality, methodological quality and generalizability of case series and cohorts in total 
hip and total knee arthroplasty with a focus on aseptic loosening. 
A web-based Delphi was conducted consisting of two internal rounds and three external 
rounds in order to achieve expert consensus on items considered relevant for reporting quality, 
methodological quality and generalizability. 
The internal rounds were used to construct a master list. The first external round was completed 
by 44 experts, 35 of them completed the second external round and 33 of them completed the 
third external round. Consensus was reached on an 8-item reporting quality checklist, a 6-item 
methodological checklist and a 22-item generalizability checklist.
Checklist for reporting quality, methodological quality and generalizability for case series and 
cohorts in total hip and total knee arthroplasty were successfully created through this Delphi. 
These checklists should improve the accuracy, completeness and quality of case series and cohorts 
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Introduction
Observational studies (case series and cohorts) provide an important source of knowledge on 
total hip arthroplasty (THA) and total knee arthroplasty (TKA). In addition to personal experience, 
they are the most common type of evidence used by orthopaedic surgeons for clinical decision 
making according to a survey of the participants at the 2007 Annual Meeting of the American 
Orthopaedic Association 1. 
Nevertheless, their rank in the hierarchy of scientific evidence is lower than evidence obtained 
from randomised experiments, and they often suffer from lack of a control group, incomplete 
data collection, selection bias and confounding by indication 2. Despite these issues, case series 
and cohorts are important in signalling inferior prosthesis designs, particularly those prone to 
aseptic loosening, which accounts for 60% of THA revisions. They are therefore a valuable 
addition to clinical trials and implant registries 3-6. Further advantages are great detail, relatively 
low costs, short study completion time and a potentially high external validity due to the inclusion 
of a wide range of patients 2. 
Considering the substantial value and large volume of case series and cohorts in orthopaedic 
literature as well as the methodological issues mentioned above, it is remarkable that there is 
currently no validated measurement tool to appraise their quality 7. A validated measurement tool 
could contribute to more accurate, transparent and complete case series and cohorts, resulting in 
higher quality 8. Although STROBE is available as a guideline for reporting in observational studies 
it lacks details that are important for TKA and THA such as details on type of implant and surgical 
technique. Additionally, the STROBE-group has recently emphasized that STROBE is a reporting 
guideline and that it should not be misused for the appraisal of methodological quality 9. 
The aim of this study was therefore to develop a tool to appraise the reporting quality and 
methodological quality of case series and cohorts of lower limb arthroplasty with emphasis on 
revision for aseptic prosthesis loosening by means of a Delphi approach. The second aim was 
to construct a checklist of items that are important for the generalizability of the results of case 
series and cohorts. 
Methods
A Delphi approach was used for the development of a checklist for reporting quality, a checklist 
for methodological quality and a generalizability tool. The Delphi approach is a well recognized 
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of questionnaires 10,11. The advantages are anonymity of the participants, so avoiding dominance, 
expression of consensus by summary measures and several iterations with controlled feedback, 
which allows individuals to change their opinion in light of the group’s response. A Delphi takes 
full advantage of both the research and clinical experience of the involved experts while imposing 
no geographical limitations on participation 10. 
Design of Delphi
An internet-based Delphi design was adapted from Graham et al. and the reporting was according 
to the CHERRIES guidelines for reporting results of internet E-surveys 12,13. The focus of the Delphi 
was on the revision rate for aseptic loosening in TKA and THA. During the conceptual phase we 
determined that the checklists should require quality items (internal validity) and generalizability 
items (external validity) specific for TKA and TKA. Furthermore the quality items should include 
items for the appraisal of selection bias, confounding by indication and competing events 2,14. 
Additionally, the checklists had to be easy to use, be able to be completed in an acceptable 
amount of time and had to allow for the possibility that items be scored as “unknown” in cases 
with insufficient information. 
A master list of relevant items was created as a pre-checklist to allow external experts to asses 
the face validity and to further develop the final checklist through a Delphi method in an efficient 
fashion with the desire to optimize the construct validity. This kind of approach is common for 
consensus development through a Delphi  15-17. The master list was generated from items of a 
recent systematic review of the literature and from the Equator Network website http://www.
equator-network.org/ webcite  18,19. The authors of the manuscript, the internal working group, 
achieved consensus after evaluating and revising this master list in two internal rounds. The 
actions of the internal working group consisted of the rephrasing of selected items, so that 
these items met the requirements described above. Since item generation for the master list is an 
important initial step that may determine the course of the Delphi, we ensured that the members 
of the internal working group covered all fields (TKA, THA and epidemiology) of the Delphi, that 
no items were discarded during the internal rounds and that the master list was as comprehensive 
as possible. Additional aims of the internal rounds were completion of the master list and further 
testing and fine tuning of the web-based Delphi survey form. During the external rounds of the 
Delphi survey the internal working group analyzed and discussed the external experts’ answers 
after each round, modified the list of items accordingly and rephrased, merged and clarified 
individual items to optimize their clarity and conciseness. 
The Delphi survey consisted of three external rounds and the external experts consulted were 
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accordance with the principles of a Delphi survey each expert remained blind to the identity of 
other experts. The experts who completed the first external round were invited to participate in 
the second and third external rounds. During the second and third round the experts received a 
newly created checklist which was modified according to the results of the preceding round. Each 
item of the newly created checklist was presented with a summary of the groups’ response to 
allow the experts change their answer in view of the groups’ response 13. 
Invited experts were identified via Pubmed and were required to have had at least one international 
peer-reviewed publication in the last three years in the field of TKA, THA or evidence based 
medicine in more general terms (expertise in musculoskeletal field or reporting guidelines or 
advised by one of the authors). One reminder was sent to those experts who did not respond 
during the first external round. Four reminders were sent to non responders during the second 
and third external rounds. The reminders consisted of a personal e-mail message sent by the 
internal experts when applicable, in order to maximize the response rate  20. The first internal 
round commenced in July 2009 and the last external round was concluded in June 2011. 
Design and handling of the E-survey
An electronic form was created in Google documents comprising 50 items in the first internal 
round, 42 items in the second internal round, 45 items in the first external round, 48 items in the 
second external round and 22 items in the third external round (only generalizability). The survey 
consisted of general items (e.g. expert name; remarks boxes), quality items and generalizability 
items. 
External experts were invited by e-mail to complete the online survey. This e-mail contained a link 
to the survey, information regarding the purpose of the Delphi and an estimate of the duration of 
the survey as derived from the internal rounds. Experts were informed that they would be invited 
for further rounds before opening the survey. The only incentive used was an offer to the external 
experts of a mention in the acknowledgements on the condition of completion of two rounds. 
All items of the survey, except the remarks boxes, were required items. Omitted questions were 
highlighted in cases with an incomplete submission. The survey consisted of a mixture of multiple-
choice and open questions and included text boxes for remarks in order to take full advantage 
of the knowledge of the expert panel and to ensure creativity of the items. Furthermore all the 
multiple-choice questions in the first external round had the “other” option with a free text 
field, so that no restrictions were placed on the answers of the experts. Additionally, opportunity 
was given to the experts to add items, to modify wording of items and to give explanations and 
reasons for their answers. Text boxes for remarks ensured that experts could make additions, 
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Each expert had to answer all questions. Since the survey comprised multiple areas of expertise 
the experts could choose the option “no opinion” when necessary. Experts were able to view and 
change their answers before submission. 
Experts were also asked for their names and e-mail addresses in order to prevent duplicate entries 
from the same individual. 
Domains of the Delphi
The three domains of the Delphi checklist were reporting quality, methodological quality and 
generalizibility. 
Reporting quality and methodological quality
The Delphi distinguished between reporting quality and methodological quality, because while 
reporting quality is particularly important for transparency, methodological quality is helpful in 
appraising and understanding the sources and magnitude of bias in a study 9. Accordingly, a study 
with a high level of reporting quality may be methodologically unsound (low methodological 
quality) and vice versa. 
Generalizability
The fact that two studies will never be completely identical poses difficulties for the comparability 
and generalizability of their results  21. Since patient demographics, component positioning, 
post operative functioning (activity level) and regional influences may all affect revision rates for 
aseptic loosening, so it is important to investigate to what extent each factor may differ between 
two studies 5,22-24. For example, are the results of a study with 60% female patients comparable 
to those of a study with 90% female patients when all other factors are the same? Does each 
factor need to be exactly the same or are small differences acceptable and if so, to what extend? 
In order to identify relevant items, the experts were asked to select items that are important for 
case series and cohorts with aseptic loosening in TKA and THA. When an item was chosen they 
were then asked to specify the extent of the allowable difference, for each relevant factor, that 
would be acceptable when comparing different studies in terms of generalizibility. 
Statistical analysis
Standard descriptive statistics were used. For an item to be included in the final checklists it must 
have been selected by at least two thirds of the experts 25. 
For generalizibility items the mode was determined, which is the value that was chosen most 








































AQUILA: assessment of quality in lower limb arthroplasty  |  85
6
number of experts who chose the mode value by the total number of experts who considered 
the generilizability item relevant (NMode/NTotal ) The preference was considered high in case 80% 
or more of the experts chose the mode value. The preference was considered moderate in case 
67% to 80% of the experts chose the mode value and the preference was considered low in case 
fewer than 67% of the experts chose the same value. 
The “no opinion” answers were not used for the calculation of agreement, because this option 
could be used by experts when faced with a question outside the scope of their expertise. 
Results
Delphi flow
An overview of the Delphi flow and the number of experts involved in each round is depicted in 
Figure 6.1. Of the 272 experts contacted, 44 agreed to participate and completed the first external 
round. 37 of them also completed the second (n = 35) or third (n = 33) external round. These 37 
external experts form the basis of this Delphi and had a mean experience of 16 years (range 3 
to 30 years; S D7.5), see Table 6.1 for the area of expertise. The professional background of the 
experts was as follows: 30 orthopaedic surgeons or residents, 5 epidemiologists, 1 biomedical 
engineer and 1 physical therapist. The mean number of publications for all expert was 80 (range 
2 to 445). The experts were of the following 17 nationalities covering 5 continents: American, 
Argentinean, Australian, Austrian, Belgian, British, Danish, Dutch, Finish, French, German, Indian, 
Israelian, Italian, Spanish, Swedish and New Zealander. Additional characteristics of the experts 
are presented in Table 6.1. The mean total completion time for all external rounds was 32 minutes 
SD 13 (range 17 to 65 minutes). There were no apparent differences in ratings and answers 
between the experts who completed both external rounds and those who only participated in 
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Figure 6.1 Flowchart. Overview of the Delphi flow and the number of experts involved in each round.
Table 6.1: Characteristics of experts (N = 37) who completed both external rounds
Count
Area of expertisea
•	 Hip surgery 24
•	 Knee surgery 20







a  Multiple answers for each expert are possible. Therefore the total is more than 35.
b  One expert indicated “Implant Biology” in the other field. The remaining 6 answers in the other field were 
in addition to either “Hip surgery”, “Knee surgery” or “EBM”
c  One expert indicated “Private Research Center” in the other field. The remaining answer in the other field 
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Reporting quality and methodological quality
At the beginning of round 1 the Delphi consisted of two domains as determined by the internal 
working group: quality (internal validity) and generalizability (external validity) After round 1 a 
clear distinction between reporting items and methodological items was made, as suggested by 
one of the external experts. The quality items were therefore allocated to either the reporting 
quality checklist or methodological quality checklist. Furthermore, the FU-quotient has been 
added to methodological quality item nr 3, as suggested by one of the external experts  26. 
Additional modifications after round 1 consisted mainly of rephrasing. Some items were divided 
into two separate items (5 years post-operatively and 10 years post-operatively). Following round 
1 these items were compiled into one item without a time specification. 
By the second external round, agreement was reached on eight items relating to reporting quality 
as well as on six items on methodological quality. Additionally, 21 of the 35 experts indicated that 
a case series or cohort should include at least 100 arthroplasties at baseline in order to accurately 
determine the number of revisions or revision rate. The answers ranged from a minimum of 
40 to a minimum of 300 arthroplasties. The final list of items covering reporting quality and 
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Table 6.2: The final AQUILA checklist for use by authors
Reporting Quality Item
1. Are the in- and exclusion criteria clearly reported?
2. Is information adequately reported regarding the number of patients who did not gave informed 
consent and who were not willing to participate?
3. Are the baseline characteristics of included patients reported?
4. Is the surgical technique adequately reported?
5. Are the prosthesis brand and fixation reported with enough detail?
6. Are the reasons or definitions for revision adequately reported?
7. Are the number of revisions (N) and revision rates regarding aseptic loosening (either Kaplan-
Meier or life table or revisions per 100 observed component years) adequately reported?
8. Are the number of deaths, lost-to-follow up (e.g. no show at clinic or emigration), amputations, 
and revisions other than the primary endpoint adequately reported?
Methodological Quality Item
1. Is there a clear primary research question / hypothesis?*




3. How was the adequacy of follow-up (FU)? 
a. Fully completed FU 
b. 5% or less lost-to-FU or FU quotientb is 1 or less
c. More than 5% lost-to-FU or FU quotient is more than 1
d. Unknown
4. How as the FU performed?
a. Predefined e.g. yearly
b. When patient had complaints or chart review (of non-predefined FU)
c. Unknown
5. How many arthroplasties are at risk at the FU of interest?
a. 20 or more
b. Less than 20
c. Unknown
6. Is a worst case analysis or competing risk analysis for competing endpoints[28] performed?
* In case of aseptic loosening: Does the research question or hypothesis include revision of the component 
due to aseptic loosening? 
a Consecutively is defined as all patients receiving an arthroplasty (TKA or THA) in a defined period of time 
have also received the arthroplasty of interest. The following situation is therefore non-consecutive: all 
patients receiving prosthesis X while prosthesis Y has also been used for the same indication during that 
period of time.
b FU quotient = Number of lost to follow up / Number of failures 26
Generalizibility
After round 1 the following items were dropped from the checklist, because less than two thirds 
of the external experts found them relevant: Hospital for Special Surgery Score (TKA), Merle 
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were added to the checklists, as suggested by one of the experts: KOOS (TKA), WOMAC (TKA), 
Oxford Knee Score (TKA), HOOS (THA), WOMAC (THA) and Oxford Hip Score (THA). All these six 
items were considered relevant in the third round and thus remained in the final checklist. 
Twenty-two items, related to the comparison of revision rates between studies, were agreed 
upon by the third external round. These items comprised domains of patient demographics, 
component positioning, post-operative functioning and regional influences. The final list of these 
generalizability items can be found in Table 6.3.
Table 6.3: Expert agreement to allowed difference of generalizability items between two studies 
Generalizability item Mode a NMode of NTotal (%)
b Preference for 
mode valuec
Patient demographics
Age 5 years 22 of 31 (71) M
Gender 10% 20 of 30 (67) M
Diagnosis 10% 17 of 31(55) P
BMI 5 points 16 of 29 (55) P
Component positioning
TKA 
Hip Knee Angle 5 degrees 13 of 24 (54) P
Varus/valgus tibial component 3 degrees 17 of 25 (68) M
Slope of tibial component 3 degrees 15 of 24 (63) P
THA
Inclination of acetabular cup 10 degrees 19 of 28 (68) M




Knee Society Score 10 points 18 of 23 (78) M
Knee Society Function Score 10 points 20 of 24 (83) G
Range of Motion 10 degrees 18 of 24 (75) M
KOOS 10 points 11 of 17 (65) P
WOMAC Knee 10 points 11 of 19 (58) P
Oxford Knee Score 5 points 18 of 24 (82) G
THA 
Harris Hip Score 10 points 17 of 21 (81) G
HOOS 10 points 12 of 17 (71) M
WOMAC Hip 10 points 12 of 20 (60) M
Oxford Hip Score 5 points 16 of 22 (73) M
Regional influences
Are the studies from the same region (developing country or western countries // continents)?
Are the studies similar in type en experience of the surgeon (academic; high volume; consultant; trainee)?
Are two studies similar regarding hospital type (developer hospital/ special institute/ regular hospital)?
A Mode: the value that was chosen most frequently (e.g. 5 years) 
b NMode = the number of experts who chose the mode value 
NTotal = the total number of experts who considered the generalizability item relevant 
c H = High preference, 80% or more of the experts chose the mode value 
M = Moderate preference, between 67% and 80% of experts chose the mode value
L = Low preference, less than 67% of experts chose the mode value
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Discussion
The AQUILA initiative resulted in a checklist for reporting quality, methodological quality and 
generalizability for case series and cohorts of total hip and total knee arthroplasty. The STROBE 
guidelines are already available for use in reporting original patient research in TKA and THA. The 
AQUILA checklist now adds to these guidelines, as a treatment specific extension of STROBE, 
addressing items that are specific for TKA and THA in observational studies. Additionally, the 
AQUILA checklist addresses both methodological quality and generalizability, while STROBE is 
strictly a reporting guideline  9. Since there are currently no specific checklists available for the 
assessment of case series or descriptive cohorts in lower limb arthroplasty, nor in orthopaedics 
in general, the AQUILA checklists should have an important role in improving the accuracy, 
completeness and quality of TKA-and THA-related case series and cohorts 8. 
In terms of generalizability, there was consensus on the items that are relevant when comparing 
revision rates between studies, although in round 3 most of the included postoperative functioning 
items only just reached the cut off point of two thirds. However, the preference for the mode 
values (e.g. 5 years) was mostly moderate and even low for some items. This was most notable 
for component positioning and some functional outcome scores and may be a reflection of 
the ongoing research into the development of a core set of outcome measures and the current 
controversy in literature regarding neutral alignment of prostheses 27,28. 
We should also note some limitations. As mentioned above, although consensus was achieved on 
the relevance of the generalizability items, the preference for the mode value (e.g. 5 years) was 
mostly moderate and even low for some items. The latter should therefore be interpreted with 
some caution. Furthermore, the application of a pre-checklist may have dampened the creativity 
of the external experts. However, this approach has been successfully used in the development 
of other checklists 15-17. 
The possibility that the results were affected by non-responder bias should also be considered. 
As is the case for all surveys, the responders may have different opinions to those of the non-
responders. However, experts who participate in a survey can be very similar to those who 
decline, as demonstrated by a study from McKee et al 29. Indeed, the final expert panel in our 
study consisted of a balanced sample representative of the international musculoskeletal scientific 
community involving 17 nationalities on five different continents and included experts with a 
wide range of experience (mean 16 years range 3 to 30 years). Furthermore, the face validity of 
the checklists was good and at least 88% of the experts with an opinion consider the reporting 
quality and methodological quality items relevant. Moreover, the experts were unanimous in 8 
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The participation rate was 44/272 (16%). This is towards the lower end of participation rates 
commonly achieved in this type of survey 20,30. The number of experts who completed at least 
two external rounds (n = 37) is respectable, considering that some Delphi’s are based on as 
few as 12 experts 11,13. Our aim was to obtain a balanced and representative sample of experts 
thus minimizing bias due to the selection of a small group of experts with a particular opinion. 
This highly sensitive approach could therefore have resulted in a dilution of available and 
interested experts. Accordingly, the response rate of the first external round is the trade off for 
the representative and balanced sample of experts obtained in our study. Furthermore, as only 
complete responses were recorded, incomplete responses could have been missed. Nevertheless 
44 experts responded to the first external round and the response rate in the second (80%) and 
third (75%) external rounds was high. 
It is not uncommon that studies of the same type of TKA or THA report rather different revision 
rates 31. What factors have caused this difference? Are dissimilarities in patient demographics the 
cause, or component positioning, or post-operative functioning or perhaps regional influences 
(including skill and experience of the surgeon)? The generalizabity checklist provides a tool to help 
address this issue. For example: if the difference in mean age between two study populations is 
lager than 5 years, age is considered an important factor according to the results of the AQUILA. 
Although the name Assessment of Quality in Lower limb Arthroplasty may suggest otherwise, 
the AQUILA was developed specifically for THA and TKA, and does not include Total Ankle 
Arthroplasty (TAA) or other types of lower limb arthroplasty. However, some of the reporting 
and methodological quality items may also be useful for the appraisal of these types of lower 
limb arthroplasty studies, since the mechanisms of bias (e.g. selection bias and competing risks) 
are the same  2,14. On the other hand, the recommended minimal number of arthroplasties at 
baseline (100) may not be realistic for TAA Studies. Some of the generalizibility items, especially 
regarding component positioning and post-operative functioning may also not be applicable to 
TAA studies. 
While the AQUILA checklist was specifically developed for revision rates for aseptic loosening, it 
may also be useful for other endpoints in lower limb arthroplasty, such as revision rates for septic 
loosening or revision for other reasons, since the mechanisms of bias are the same 2,14. 
In conclusion, the AQUILA checklist is the first tool that can be used to assess the quality of 
reporting, methodology and generalizibility in case series and cohorts in lower limb arthroplasty. 









































92  |  Chapter 6
Authors’ contributions
The following authors designed the study BP, EV, HH, RN, SM, analyzed the data BP, HH, wrote 
the manuscript BP, HH, OD and ensured accuracy of data and analysis HL, RN, OD, SM. All authors 
were involved as internal experts for the creation of the master list, completed both two internal 
rounds and assisted during the external rounds. Critical revision of the manuscript was performed 
by all authors. All authors read and approved the final manuscript.
Acknowledgement 
We would like to express our gratitude to the following experts, mentioned below in alphabetical 
order. Their help, expertise and useful remarks have been of great importance for the AQUILA 
initiative: 
Per Aspenberg, Rob de Bie, Maarten Boers, Patrick Bossuyt, René ten Broeke, Martin Buttaro, David 
Campbell, Jean-Alain Epinette, Antti Eskelinen, Richie Gill, Taco Gosens, David Gwynne-Jones, 
Daniel Hernandez-Vaquero, Richard Iorio, Jean-Yves Jenny, Elizabeth Lingard, Leonid Kandel, 
Johan Kärrholm, Lucien Keijser, Christiaan Keurentjes, Steffen Kohler, Gerold Labek, Jean-Michel 
Lafosse, Mariska Leeflang, Aditya V. Maheshwari, Callum McBryde, Søren Overgaard, Rudolf W. 
Poolman, Jose M. Quintana, Dario Regis, Stephan Röhrl, Bart Swierstra, Matthias Therbo, Andrew 
Toms, Riekie de Vet, Maarten de Waal Malefijt, Ate Wymenga. 
Note that their participation in this study does not imply full agreement with the final checklist 
of items. 
This Delphi was funded by a grant from the Atlantic Innovation Fund (Atlantic Canada 
Opportunities Agency) Contract No. 191933. The Atlantic Innovation Fund did not take part in 
the design or conduct of the study; in the collection, management, analysis, or interpretation of 








































AQUILA: assessment of quality in lower limb arthroplasty  |  93
6
References
1.  Schemitsch EH, Bhandari M, McKee MD, Zdero R, Tornetta P, McGehee JB, Hawkins RJ: 
Orthopaedic surgeons: artists or scientists? J Bone Joint Surg Am 2009, 91(5):1264-1273. 
2.  Kooistra B, Dijkman B, Einhorn TA, Bhandari M: How to design a good case series. J Bone Joint 
Surg Am 2009, 91(Suppl 3):21-26. 
3.  Medical Devices Agency. Hazard notice. London: MDA, 1998 (MDA9801) 
4.  Norton MR, Vhadra RK, Timperley AJ: The Johnson-Elloy (Accord) total knee replacement. Poor 
results at 8 to 12 years. J Bone Joint Surg Br 2002, 84(6):852-855. 
5.  Swedish Hip Arthroplasty Registry Report 2008 [https://www.jru.orthop.gu.se/] website accessed 03-
08-2010
6.  Franklin J, Robertsson O, Gestsson J, Lohmander LS, Ingvarsson T: Revision and complication 
rates in 654 Exeter total hip replacements, with a maximum follow-up of 20 years. BMC Musculoskelet 
Disord 2003, 4:6. 
7.  Simera I, Moher D, Hoey J, Schulz KF, Altman DG: A catalogue of reporting guidelines for health 
research. Eur J Clin Invest 2010, 40(1):35-53. 
8.  Simera I, Moher D, Hirst A, Hoey J, Schulz KF, Altman DG: Transparent and accurate reporting 
increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR 
Network. BMC Med 2010, 8:24. 
9.  Da Costa BR, Cevallos M, Altman DG, Rutjes AWS, Egger M: Uses and misuses of the STROBE 
statement: bibliographic study. BMJ open 2011. 
10.  Jones J, Hunter D: Consensus methods for medical and health services research. Bmj 1995, 
311(7001):376-380. 
11.  Myers H, Thomas E, Dziedzic K: What are the important components of the clinical assessment of 
hand problems in older adults in primary care? Results of a Delphi study. BMC Musculoskelet Disord 
2010, 11:178. 
12.  Eysenbach G: Improving the quality of Web surveys: the Checklist for Reporting Results of Internet 
E-Surveys (CHERRIES). J Med Internet Res 2004, 6(3):e34. 
13.  Graham B, Regehr G, Wright JG: Delphi as a method to establish consensus for diagnostic criteria. J 
Clin Epidemiol 2003, 56(12):1150-1156. 
14.  Biau DJ, Latouche A, Porcher R: Competing events influence estimated survival probability: when is 
Kaplan-Meier analysis appropriate? Clin Orthop Relat Res 2007, 462:229-233. 
15.  Boutron I, Moher D, Tugwell P, Giraudeau B, Poiraudeau S, Nizard R, Ravaud P: A checklist to 
evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus. J Clin 
Epidemiol 2005, 58(12):1233-1240. 
16.  Cook C, Brismee JM, Pietrobon R, Sizer P, Hegedus E, Riddle DL: Development of a Quality 
Checklist Using Delphi Methods for Prescriptive Clinical Prediction Rules: the QUADCPR. J Manipulative 
Physiol Ther 2010, 33(1):29-41. 
17.  Mokkink LB, Terwee CB, Knol DL, Stratford PW, Alonso J, Patrick DL, Bouter LM, de Vet HC: 
Protocol of the COSMIN study: COnsensus-based Standards for the selection of health Measurement 
INstruments. BMC Med Res Methodol 2006, 6:2. 
18.  Sanderson S, Tatt ID, Higgins JP: Tools for assessing quality and susceptibility to bias in observational 
studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol 2007, 
36(3):666-676. 









































94  |  Chapter 6
20.  Sprague S, Quigley L, Bhandari M: Survey design in orthopaedic surgery: getting surgeons to 
respond. J Bone Joint Surg Am 2009, 91(Suppl 3):27-34. 
21.  Dekkers OM, von Elm E, Algra A, Romijn JA, Vandenbroucke JP: How to assess the external 
validity of therapeutic trials: a conceptual approach. Int J Epidemiol 2010, 39(1):89-94. 
22.  Swedish Knee Arthroplasty Registry Report 2009 V1.0 [http://www.knee.se] webcite accessed 
03-08-2010
23.  Bordini B, Stea S, De Clerico M, Strazzari S, Sasdelli A, Toni A: Factors affecting aseptic loosening 
of 4750 total hip arthroplasties: multivariate survival analysis. BMC Musculoskelet Disord 2007, 8:69. 
24.  Hernandez-Vaquero D, Suarez-Vazquez A, Fernandez-Lombardia J: Charnley low-friction 
arthroplasty of the hip. Five to 25 years survivorship in a general hospital. BMC Musculoskelet Disord 
2008, 9:69
25.  van Hulst LT, Fransen J, den Broeder AA, Grol R, van Riel PL, Hulscher ME: Development of 
quality indicators for monitoring of the disease course in rheumatoid arthritis. Ann Rheum Dis 2009, 
68(12):1805-1810. 
26.  Murray DW, Britton AR, Bulstrode CJ: Loss to follow-up matters. J Bone Joint Surg Br 1997, 
79(2):254-257. 
27.  Poolman RW, Swiontkowski MF, Fairbank JC, Schemitsch EH, Sprague S, de Vet HC: Outcome 
instruments: rationale for their use. J Bone Joint Surg Am 2009, 91(Suppl 3):41-49. 
28.  Morgan SS, Bonshahi A, Pradhan N, Gregory A, Gambhir A, Porter ML: The influence of 
postoperative coronal alignment on revision surgery in total knee arthroplasty. Int Orthop 2008, 
32(5):639-642. 
29.  McKee M, Priest P, Ginzler M, Black N: How representative are members of expert panels? Qual 
Assur Health Care 1991, 3(2):89-94. 
30.  Pibouleau L, Boutron I, Reeves BC, Nizard R, Ravaud P: Applicability and generalisability of 
published results of randomised controlled trials and non-randomised studies evaluating four 
orthopaedic procedures: methodological systematic review. Bmj 2009, 339:b4538. 
31.  Labek G, Frischhut S, Schlichtherle R, Williams A, Thaler M: Outcome of the cementless Taperloc 
stem: a comprehensive literature review including arthroplasty register data. Acta Orthop 2011, 
82(2):143-148. 
Chapter 7
Early migration of tibial components is 
















































96  |  Chapter 7
Abstract
We performed two parallel systematic reviews and meta-analyses to determine the association 
between early migration of tibial components and late aseptic revision. 
One review comprised early migration data from Radiostereometric analysis (RSA) studies, 
while the other focused on revision rates for aseptic loosening from long term survival studies. 
Thresholds for acceptable and unacceptable migration were determined according to that of 
several national joint registries: <5% revision at 10 years. 
Following an elaborate literature search 50 studies (847 Total Knee Prostheses(TKP)) were included 
in the RSA-review and 56 studies (20,599 TKP) were included in the survival-review. The results 
showed that for every mm increase in migration there was an 8% increase in revision rate, which 
remained after correction for age, sex, diagnosis, hospital type, continent, and study quality. 
Consequently, migration up to 0.5 mm was considered acceptable during the first post-operative 
year, while migration of 1.6 mm or more was unacceptable. TKP with migration between 0.5 and 
1.6 mm were considered at risk for revision rates higher than 5% at 10 years. 
There was a clinically relevant association between early migration of TKP and late revision for 
loosening. The proposed migration thresholds can be implemented in a phased evidence-based 
introduction of new types of knee prostheses, since they allow early detection of high risk TKP 
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Introduction
Worldwide several hundred thousand Total Knee Prostheses (TKP) are implanted each year and 
this number is expected to increase by a factor 6 within the next 2 decades 1,2. Most of the new 
TKP designs have been introduced on the market without demonstrating safety or effectiveness 3. 
This has resulted in the widespread use of TKP with failure rates exceeding 10 times the standard 
of national joint registries (5% failures at 10 years follow-up), such as the Accord, St Leger and 
Journey-Deuce 3-6. As a response several countries have developed guidelines to guarantee patient 
safety e.g. the NICE guidelines for total hip prostheses 7. Furthermore, it has become increasingly 
evident that a phased evidence-based introduction, as is common for pharmaceuticals, is needed 
to regulate the introduction of new TKP to the market 8-10. This should include systematic 
assessment and early detection of the major cause of TKP failure, which is aseptic loosening of 
the tibial component necessitating revision surgery 7,11. 
Although it may take 10 years before loosening may cause symptoms, it is possible to detect 
loosening early post-operatively with Radiostereometric analysis (RSA) 12-15. Since, RSA allows in 
vivo, three-dimensional measurement of the migration of TKP with an accuracy of 0.2mm for 
translations and 0.5 degrees for rotations, only a small number of patients have to be exposed to 
potentially unsafe TKP 13,14,16. RSA could therefore play an important role in the phased evidence-
based introduction of new TKP 12,13,15. However, the evidence for the relation between early 
migration and TKP revision for aseptic loosening is limited to a few studies from the 1990s 
13,14. Furthermore, the applicability of these studies is restricted, because both surgical technique, 
fixation methods, implant design and polyethylene have evolved since their publication. 
We hypothesize that early migration of the tibial component, measured through RSA, is associated 
with late revision for aseptic loosening in TKP. Therefore, we set out to systematically review the 
association between early migration and late aseptic revision for the tibial component in TKP. 
Ultimately, this could lead to clinical guidelines to be used in a phased introduction of new TKP.
Methods
We performed two parallel systematic reviews (international registration number NTR2417; 
www.trialregister.nl) on studies of patients treated with TKP for end stage osteoarthritis (OA) and 
rheumatoid arthritis (RA). One review comprises early migration data of TKP from RSA studies. In 
the other we determined the long term revision rates for aseptic loosening of TKP from survival 
studies. Figure 7.1 shows the flow of the systematic reviews. During all phases of the review, a 
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Systematic review of RSA studies
Literature search
A thorough literature search was performed together with a medical librarian, JP, to reduce bias 
by increasing the likelihood of retrieving all relevant studies 17. The following bibliographies were 
searched up to 2009: PubMed, Embase, Web-of-Science and the Cochrane library. Relevant 
articles were screened for additional references. Additionally, a separate search was conducted 
within nine leading orthopaedic and biomechanical journals (Acta Orthop, Clin Orthop Rel Res, J 
Arthroplasty, J Bone Joint Surg (Am and Br) Knee Surg Sports Traumatol Arthrosc, J Orthop Res, 
J Biomec and Clin Biomech). Finally, Google Scholar was used. Articles in English, French, Italian, 
Spanish, Dutch and German were considered. The search strategy consisted of the following 
components, each defined by a combination of controlled vocabulary and free text terms: 1) RSA; 
and 2) Joint replacement. 
Inclusion and exclusion analysis
Initial screening on title and abstract of RSA studies was performed by BP to identify studies on 
patients treated with TKP for end stage OA or RA. In case the information in the abstract did not 
suffice or in case of any doubt, the studies remained eligible. The full text of eligible studies was 
independently evaluated in duplicate by two reviewers, BP and EV. The inclusion criteria for RSA 
studies were 1) primary TKP and 2) minimal RSA follow-up of 1 year, measuring tibial component 
migration. Non-clinical studies (animal, phantom) were excluded. 
 
Data extraction
BP and KN independently extracted migration data in duplicate from the RSA studies. Migration 
data comprised translations, rotations and Maximal Total Point Motion (MTPM) of the tibial 
component in the 1st post-operative year. MTPM is the unit of measurement for the largest 
3D-migration of any point on the prosthesis’ surface 13. Data concerning patient demographics 
and regional influences were also extracted to allow for confounder correction. 
Quality Assessment 
The quality of the RSA studies was independently appraised in duplicate by BP and KN at the 
level of outcome using the AQUILA methodological score 18. For the RSA studies we modified the 
AQUILA by removing items not considered relevant for early migration: long term follow-up and 
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Systematic review of survival studies
Literature search
The search strategy and bibliographies are the same as those in the RSA review with the exception 
of the components of the search strategy. The search strategy of the survival studies consisted of 
the following components, each defined by a combination of controlled vocabulary and free text 
terms: 1) Joint replacement; 2) Implant failure; and 3) Survival analysis. In the search strategy no 
distinction was made between total knee and total hip prostheses (THP), because some studies 
report on TKP as well as THP 19.
Inclusion and exclusion analysis
The procedure of screening the survival studies for eligibility and subsequent inclusion and 
exclusion analysis was identical to the procedures of the RSA studies with the exception of 
inclusion and exclusion criteria. The inclusion criteria for survival studies were 1) primary TKP; 
2) follow up of 5, 10, 15, 20 or 25 years; 3) endpoint revision surgery for aseptic loosening of 
the tibial component, or indication for revision surgery in case of poor general health or patient 
decline; and 4) survival or percentage revised must be available for specific follow-up (see point 
2). Studies with less than 75 TKP at baseline were excluded.
Data extraction
BP and KN independently determined the revision rates in duplicate for aseptic loosening of 
the tibial component at 5 year intervals from the survival studies. Data concerning patient 
demographics and regional influences were extracted to allow for confounder correction. 
Quality assessment
The quality of the survival studies was independently appraised in duplicate by BP and KN at the 
level of outcome using the AQUILA methodological score 18. 
Analysis
A detailed description of the analysis, methodology and a worked example is available in Chapter 
9. To determine the association between early migration and late revision we matched the 
results from the RSA review to the results of the survival review on type of Prosthesis, Fixation 
method (e.g. cement or bone ingrowth) and articulating Insert (e.g. modular or non-modular). 
The combination was termed PFI. Since PFI are technical factors known to be associated with 
both migration and the likelihood of revision for aseptic loosening, matching on PFI prevents 
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one combination of matching RSA and survival studies for a particular PFI. For instance, if there 
are 3 RSA studies and 2 survival studies of the same PFI, then there are 6 possible combinations (3 
times 2). All combinations were considered in the analysis. A meta-analysis for the revision rate at 
5 years was performed. A model for the censoring mechanism was employed to reconstruct the 
data and then a generalized linear mixed model with study as a random effect has been applied 
to estimate the survival at 5 years and its confidence interval 23-25. Regarding the RSA studies 
pooling of migration results at the level of PFI was based on weights according to study size (N).
The 10 year results of TKP with high revision rates may not be published once the 5 year results 
have been published. Since 10 year revision rates in the registries are on average 1.7 times higher 
than 5 year revision rates, any missing 10 year results were estimated on 5 year results by applying 
a factor of 1.7. This method was validated by comparing the estimated 10 year results with the 
known 10 year results, for the complete cases 11,20-22. 
Adjustment for confounding 
Since migration data and revision rate data were extracted from different studies, it is possible 
that differences between study populations may confound the observed association. In order to 
address this issue we determined the degree of similarity of the population from RSA and survival 
study combinations, expressed by a match score, for age, gender, diagnosis, hospital type, and 
continent. The match score is constructed according to the results of a recent Delphi among an 
international group of 37 independent experts and can vary between 5 (excellent) and 0 (poor) 
18. The RSA study and survival study combination score 1 point for each of the following criteria 
(up to a maximum of 5 points):
•	 the difference in the mean age between the patients from RSA study and those from 
the survival study was 5 years or less. 
•	  the difference in percentage females between the RSA study and survival study was 
10% or less. 
•	  the difference in percentage patients diagnosed with osteoarthritis between the RSA 
study and survival study was 10% or less. 
•	  the RSA study and survival study were performed in the similar hospital type (e.g. both 
university medical centers). 
•	 the RSA study and survival study were performed on the same continent. 
All other cases score zero points.
We used a weighted regression model to assess on the association between early migration and 
late aseptic revision corrected for match score, RSA study quality, survival study quality, number 
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Migration thresholds 
According to the principle of “primum non nocere“ (first do no harm), new implant designs 
should perform at least as well as the revision standard of national registries: 3% revision at 
5 years and 5% revision at 10 years according to the Swedish Knee Arthroplasty Registry 20. 
Based on this revision standard the following three categories were constructed for the phased 
introduction of new TKP: acceptable, at risk and unacceptable. The acceptable category was 
defined as the level of migration up to which all survival studies have lower revision rates than 
the standard. The unacceptable category was defined as the level of migration from which all 
revision rates are higher than the standard. The category at risk is defined as the migration 
interval between the acceptable and unacceptable thresholds, in which studies with revision rates 
lower and higher than the standard were observed. 
Appraisal of publication bias
We assessed the potential effect of publication bias by comparing the results from the meta-
analysis to the results from national joint registries, since they do not suffer from publication 
bias 11,20-22. Accordingly, the PFI that perform better than average in the meta-analysis should 
also perform better than average in the national joint registries. The same principle also applies 
to PFI that perform worse than average. For this purpose the migration pooled by PFI was sorted 
according to revision rate pooled by PFI and visualized in a dot chart 26.
Results
RSA studies
The literature search yielded 629 hits for the RSA review and 50 studies were included with a 
total of 847 patients 16,27-68. Details on study selection and flow of the review are shown in Figure 
7.1. The mean quality score of the RSA studies was 3.8 (SD 1.7) on a 7-point scale. MTPM at 1 
year was the most frequently and most consistently reported migration value: 44 out of 50 RSA 
studies reported it. Translations and rotations of the tibial component were reported infrequently 
and inconsistently and did not allow a meaningful analysis. All analyses will therefore focus on 
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138 Eligible 722 Eligible
491 abstracts excluded


























17 duplicates removed 1391 duplicates removed
4568 abstracts excluded
4568 Not primary TKP 
64 Included 218 Included
74 full-text papers excluded
5 Not primary TKP 
47 No RSA data ≥1year
7 Not Clinical
15 Doubles
504 full-text papers excluded
59 Not primary TKP
85 FU < 5 year
2 No aseptic loosening
5 No survival or % revised



































Figure 7.1: PRISMA flowchart of both reviews. Details of the 28 PFI can be found in Table 7.1.
RSA = radiostereometric analysis; TKP = total knee prosthesis; FU = follow-up; PFI = Prosthesis Fixation Insert
Survival studies
After the literature search there were 5,290 hits for the survival review and 56 studies were 
included with a total of 20.599 patients, see Figure 7.1 14,69-118. The mean quality score of the 
survival studies was 6.0 (SD 1.8) on an 11-point scale. 
Early migration and late revision
The matching procedure resulted in 28 different PFI and 89 combinations of RSA and survival 
studies, see Table 7.1. There was a clear association between early migration, expressed as MTPM 
at 1 year and the 5 year revision rate as expressed as prosthesis survival, as shown in Figure 7.2. 
For every millimeter increase in migration 7.6% [95% CI 5.7% to 9.5%], p<0.05, was added to 
the 5 year revision rate. The influences of RSA study quality, survival study quality, number of TKP 
in the RSA study, number of TKP in the survival study and match score were small relative to the 
overall effect of migration on revision rate, see Table 7.2. For TKP that rely on primary fixation 
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5 year revision rate for every 1mm increase in MTPM. For TKP that rely on secondary fixation 
(uncemented without screws) 10.1% [95%CI 2.7 to 17.4], p=0.018, was added to the 5 year 
revision rate for every 1mm increase in MTPM.
Figure 7.2 Scatterplot showing association between migration in the 1st post-operative year expressed as 
Maximal Total Point Motion (MTPM) in mm and revision rate for aseptic loosening of the tibial component 
at 5 years in percentages. The dotted lines are derived from weighted regression according to match quality, 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Early migration of tibial components is associated with late revision  |  105
7
Table 7.2: Association between MTPM at 1 year and revision rate for aseptic loosening at 5 years.
Increase in revision (%) / mm MTPM 95% CI
Crude 7.6 5.7 – 9.5
Adjusted for*:
N survival** 7.4 5.6 – 9.2
N RSA** 7.1 5.4 – 8.8
Survival study quality 8.4 6.5 – 10.3
RSA study quality 7.4 5.4 – 9.4
Total Match Score 7.6 5.6 – 9.4
Range of values:
7.1 – 8.4 5.4 – 10.3
Table 7.2 shows the increase in the 5-year revision (%) for each mm increase in MTPM at 1 year. 
In the crude analysis (unadjusted) 7.6% [95%CI 5.7% to 9.5%], p<0.05, is added to the 5-year revision rate 
for every mm increase in MTPM at 1 year.
* When adjusted for e.g. the number of TKP in survival studies (N survival) 7.4% [95%CI 5.6% to 9.2%], 
p>0.05, is added to the 5-year revision rate for every mm increase in MTPM at 1 year.
The association between MTPM1 and revision rate for aseptic loosening remains significant, when adjusting 
for confounders( all p-values <0.05).
** The square rote of N was used for the weighted regression, so larger studies weigh heavier.
N survival = number of TKP in survival studies
N RSA = number of TKP in RSA studies
Migration thresholds
Figure 7.3 shows the three categories for the TKP migration. For MTPM at 1 year between 0 and 
0.54mm there was no tibial component with more than 3% revision for aseptic loosening at 5 
years. In case of 1 year MTPM of more than 1.6mm there was no tibial component with less than 
3% revision for aseptic loosening at 5 years. This implies that accepting 3% revision at 5 year 
resulted in a threshold of 0.54mm or acceptable MTPM at 1 year and a threshold of 1.6mm for 
unacceptable MTPM at 1 year. For the 10 year revision rates, the thresholds for acceptable and 
unacceptable migration were 0·45 mm and 1·6mm respectively, see Figure 7.4. 
The mean difference between the estimated 10 year revision rate and known 10 year revision 
rate is 0.17% (SD 2.1%) indicating absence of any systematic error. The 5 year revision rates of 
the studies with missing 10 year revision rates were already higher than the 5% ten-year revision 
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Figure 7.3. Scatter plot showing the relation between MTPM at 1 year and revision of the tibial component 
for aseptic loosening at 5 years. The thresholds of 0.54 and 1.6mm for the three categories – acceptable; at 
risk; unacceptable - are shown. MTPM = Maximal Total Point Motion
Figure 7.4. Scatter plot showing the relation between MTPM at 1 year and revision of the tibial component 
for aseptic loosening at 10 years. The thresholds of 0.45 and 1.6mm for the three categories – acceptable; at 
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Publication bias
The pooled MTPM ranked by the pooled revision rate for each PFI is presented in Figure 7.5. 
The PFI that migrate significantly less than the acceptable threshold -classified as acceptable 
- have excellent track records and low revision rates in several national joint registries 11,20-22. 
Conversely, the PFI that are classified as unacceptable on basis of their pooled migration have 
been abandoned and are no longer used. The potential influence of publication bias on the 
results is therefore small.
Figure 7.5: Dotchart showing the pooled MTPM ranked by the pooled revision rate for each PFI. The 
acceptable PFI (based on migration) have excellent track records and low revision rates in several national 
registries, whereas the unacceptable PFI (based on migration) have been abandoned. Therefore the potential 
influence of publication bias on the results is small. A detailed description for each PFI is available in Table 1. 
R5(%) = pooled revision rate at 5 years follow-up in percentage.
Discussion
Results of this systematic review demonstrate a clinically relevant association between early 
migration, as measured with RSA, and long term clinical failure resulting in revision for aseptic 
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after correction for age, gender, diagnosis, hospital type, continent and study quality. This is 
more than twice the standard revision rate of several national joint registries 11,20-22. The results 
of this systematic review show that RSA studies can identify unsafe TKP (in terms of aseptic 
loosening) as early as 1 year post-operatively. Early identification of unsafe TKP with RSA prevents 
their widespread use. Compared to the present system this safeguards numerous patients from 
extensive revision surgery with potential postoperative complications. 
Some strengths of this systematic review are the large number of included studies (>100) and 
patients (>27,000) which resulted in 28 different PFI. This large variation in PFI, which reflects 
the diversity in TKP designs and fixation methods, ensures wide applicability of the results. Since 
migration and revision rates are from different studies, there is no migration data available in 
survival studies to be incorporated into the decision to perform a revision. Consequently there 
is no incorporation bias in our results. The risk of publication bias in this systematic review was 
considered to be small, since the results from the meta-analysis are similar to those from the 
national joint registries, which do not suffer from publication bias. Confounders had only a small 
influence on the association between early migration and long term aseptic revision. 
We should also consider some limitations. The quality of the survival and RSA studies showed 
large variation. High methodological quality of all included studies is desirable. Nevertheless 
survival study quality and RSA study quality showed only very small effects on the association 
between migration and revision rates. 
We focused on MTPM at 1 year post-operatively, while other migration parameters and follow-
up beyond 1 year are also of interest 13. Unfortunately, these parameters were reported too 
infrequently and inconsistently to allow a meaningful analysis. Future RSA studies could therefore 
benefit from further standardization particularly regarding the reporting of the results 119.
We also recognize that RSA only evaluates aseptic loosening while other failure mechanisms 
(e.g. infection, pain and instability or pseudotumors in metal-on-metal total arthroplasty) are not 
evaluated by RSA. As a consequence RSA studies are only the first step in the phased evidence-
based introduction as proposed by Malchau, see Figure 7.6 8. 
During phase A, multiple single center RSA studies should be performed to determine the safety 
of the TKP with regard to the risk of revision for aseptic loosening. If the TKP is considered safe, 
phase B studies have to be conducted to evaluate the clinical performance of the TKP regarding 
pain relief and functioning (clinical scores and patient reported outcome measures (PROMS)) 
and to determine the rate of expected or unexpected complications. Since RSA studies have 
already evaluated the risk of aseptic loosening, follow-up of 2 years instead of 10 years will be 
sufficient. This reduces the follow-up needed for a successful phased introduction with almost a 
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new TKP to the market before their patent has expired. After release to the market, phase C, 
the performance of the TKP has to be monitored by post-marketing surveillance in national joint 
replacement registries 10. This includes both the revision rate and patient evaluations using patient 
reported outcome measures (PROMS).
Pre Clinical Phase
Post marketing surveillance 




(MTPM 0.5 to 1.6 mm)
Unacceptable (MTPM >1.6mm)


























Figure 7.6 Flowchart showing the role of RSA studies in the phased evidence-based introduction of new TKP 
modified according the Malchau proposal. Stabilization is defined as migration of less than 0.2mm in the 
second post-operative year (MTPM from year 1 to year 2) as described by Ryd et al (1995) See discussion for 
details on each phase.
In this systematic review, RSA studies of 20 to 60 patients followed for 1 year led to the same 
conclusion as national joint registries with thousands of patients followed for 5 to10 years. 
A recent publication has shown a 22% to 35% reduction in the number of revisions of RSA-
tested total knee replacements as compared with non-RSA-tested total knee replacements in the 
national joint registries 120. Because inferior designs can already be detected early post-operatively 
exposing only a small group of patients to potentially unsafe TKP, RSA provides the necessary 
efficiency to effectuate phased evidence-based introduction. Already more than a decade ago 
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new prostheses 8,121-123. Now the observed association between early migration and long term 
revision translates into practical thresholds that can lead to clinical guidelines for phased evidence-
based introduction of new TKP. 
Various authors and regulatory agencies recognize the potential of RSA 8,13-15,124,125. The NICE 
guidelines of 2003 (United Kingdom) require adequate long-term clinical data for hip prostheses 
and indicate RSA as a promising technique that may be an alternative for long-term follow-up 
studies. The Dutch Orthopaedic Society now requires a phased introduction with mandatory RSA-
studies before any new hip prosthesis is considered for introduction to the Dutch market. Official 
guidelines for knee prosthesis are expected to follow.
In the light of the recent disasters with introducing new orthopaedic implants to the market, 
a phased clinical introduction for new TKP is mandatory to prevent patients from receiving 
potentially unsafe TKP when standard TKP with excellent long term track records are available. 
In conclusion there was a clinically relevant association between early migration of TKP and late 
revision for loosening. The proposed migration thresholds can be implemented in a phased 
evidence-based introduction, since they allow early detection of TKP with a high risk of aseptic 
loosening while exposing a small number of patients.
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Abstract
We performed 2 parallel systematic reviews and meta-analyses to determine the association 
between early migration of acetabular cups and late aseptic revision. 
One review comprised early migration data from Radiostereometric analysis (RSA) studies, 
while the other focused on revision rates for aseptic loosening from long term survival studies. 
Thresholds for acceptable and unacceptable migration were determined according the national 
joint registries: 5% revision at 10 years. 
Following an elaborate literature search 26 studies (700 cups) were included in the RSA-review 
and 49 studies (38,013 cups) in the survival-review. The results showed that for every millimeter 
increase in 2-year proximal migration there was an increase of 10% in revision rate, which 
remained after correction for age, gender, diagnosis, hospital type, continent and study quality. 
Consequently, proximal migration up to 0.2mm was considered acceptable, while proximal 
migration of 1.0mm or more was unacceptable. Cups with proximal migration between 0.2 and 
1.0mm were considered at risk for revision rates higher than 5% at 10 years. 
There was a clinically relevant association between early migration of acetabular cups and late 
revision for loosening. The proposed migration thresholds can be implemented in a phased 
evidence-based introduction, since they allow early detection of high risk cups while exposing a 
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Introduction
Worldwide several hundred thousand Total Hip Prostheses (THP) are implanted each year and this 
number is expected to double within the next decades 1,2. It is crucial to monitor the safety and 
quality of THP to prevent unneeded harm to patients and costs to society (i.e. reduction of the 
future revision burden). Most of the new THP designs are on the market without demonstrating 
safety or effectiveness 3. This has resulted in the use of several THP with high failure rates, such 
as the Wagner cup, the Link V cup and the Mecron cup 4-6. In response to these problems, 
several countries have developed guidelines to guarantee patient safety e.g. the NICE guidelines 
7. Furthermore, it has become increasingly evident that a phased evidence-based introduction, as 
is common for pharmaceuticals, is needed to regulate the introduction of new THP to the market 
8-10. This should include systematic assessment and early detection of the major cause of THP 
failure, which is aseptic loosening necessitating revision surgery11,12 
Although it may take 10 years before the final stages of loosening are visible on conventional 
radiographs, it is possible to detect loosening early post-operatively with Radiostereometric 
analysis (RSA). Since, RSA allows in vivo, 3-dimensional measurement of the migration of THP 
with an accuracy of 0.2mm for translations and 0.5 degrees for rotations, only a small number of 
patients have to be exposed to potentially unsafe THP 13,14. RSA could therefore play an important 
role in the phased evidence-based introduction of new THP. 
In this systematic review and meta-analysis we concentrated on the acetabular cup. We 
hypothesize that early migration of the acetabular cup, measured through RSA, is associated with 
late revision for aseptic loosening. Therefore, we systematically reviewed the association between 
early migration and late aseptic revision for the acetabular cup in primary THP. Eventually, this 
could lead to clinical guidelines to be used in a phased introduction of new THP.
Methods
We performed 2 parallel systematic reviews (international registration number NTR3128; www.
trialregister.nl) on studies of patients treated with THP for primary osteoarthritis (OA), secondary 
osteoarthritis (SA) and fractures of the proximal femur (FF). One review comprises early migration 
data of acetabular cups from RSA studies. In the other we determined the long term revision rates 
for aseptic loosening of acetabular cups from survival studies. Figure 8.1 shows the flow of the 
systematic reviews. During all phases of the review process, a referee – RN – with over 20 years 
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Systematic review of RSA studies
Literature search
A thorough literature search was performed together with a medical librarian, JP, to reduce bias 
by increasing the likelihood of retrieving all relevant studies 15. The following bibliographies were 
searched up to 2009: PubMed, Embase, Web-of-Science and the Cochrane library. Relevant 
articles were screened for additional references. Additionally, a separate search was conducted 
within nine leading orthopaedic and biomechanical journals (Acta Orthop, Clin Orthop Rel Res, J 
Arthroplasty, J Bone Joint Surg (Am and Br), Knee Surg Sports Traumatol Arthrosc, J Orthop Res, 
J Biomech, Clin Biomech). Finally, Google Scholar was used. Articles in English, French, Italian, 
Spanish, Dutch and German were considered. The search strategy consisted of the following 
components, each defined by a combination of controlled vocabulary and free text terms: 1) RSA; 
and 2) Joint replacement. 
Inclusion and exclusion analysis
Initial screening on title and abstract of RSA studies was performed by BP to identify studies on 
patients treated with THP for OA, SA or FF. In cases where the information in the abstract did not 
suffice or where there was any doubt, studies remained eligible. The full text of eligible studies 
was independently evaluated in duplicate by 2 reviewers, BP and MN. The inclusion criteria for 
RSA studies were 1) primary THP and 2) minimal RSA follow-up of 1 year, measuring acetabular 
cup migration. Non-clinical studies (animal, phantom) were excluded. 
 
Data extraction
BP and MN independently extracted migration data in duplicate from the RSA studies. Since the 
failure mechanism of acetabular cups consist of increasing proximal migration and increasing 
inclination the data extraction of RSA studies comprised proximal migration and inclination of the 
acetabular cup until the second post-operative year 16. Data concerning patient demographics 
and regional influences were also extracted to allow for confounder correction 17. 
Quality Assessment 
The quality of the RSA studies was independently appraised in duplicate by BP and MN at the 
level of outcome using the AQUILA methodological score 17. For the RSA studies we modified the 
AQUILA score by removing items that were not considered relevant for early migration, such as 
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Systematic review of survival studies
Literature search
The search strategy and bibliographies are the same as those in the RSA review with the exception 
of the components of the search strategy. The search strategy of the survival studies consisted of 
the following components, each defined by a combination of controlled vocabulary and free text 
terms: 1) Joint replacement; 2) Implant failure; and 3) Survival analysis. In the search strategy no 
distinction was made between total knee and total hip prostheses (THP), because some studies 
report on TKP as well as THP 18.
Inclusion and exclusion analysis
The procedure of screening the survival studies for eligibility and subsequent inclusion and 
exclusion analysis was identical to the procedures of the RSA studies with the exception of 
inclusion and exclusion criteria. The inclusion criteria for survival studies were 1) primary THP; 2) 
follow up of 5, 10, 15, 20 or 25 years (in the final analysis only 10 years follow-up was used); 3) 
endpoint revision surgery for aseptic loosening of the acetabular cup, or indication for revision 
surgery in case of poor general health or patient decline; and 4) survival or percentage revised 
must be available for specific follow-up (see point 2). Studies with less than 75 THP at baseline 
were excluded.
Data extraction
BP and MN independently determined the revision rates in duplicate for aseptic loosening 
of the acetabular cups at 5 year intervals from the survival studies. Data concerning patient 
demographics and regional influences were extracted to allow for confounder correction. 
Quality assessment
The quality of the survival studies was independently evaluated by BP and MN at the level of 
outcome using the AQUILA methodological score 17. 
Analysis
A detailed description of the analysis, methodology and a worked example is available in 
Chapter 9. To determine the association between early migration and late revision we matched 
the results from the RSA review to the results of the survival review on type of Prosthesis and 
Fixation method (e.g. cement or bone ingrowth) here abbreviated to PF. Since PF is determined by 
technical factors known to be associated with both migration and a high likelihood for revision 
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available studies, it is possible that there is more than one combination of matching RSA and 
survival studies for a particular PF. For instance, if there are 3 RSA studies and 2 survival studies of 
the same PF, then there are 6 possible combinations (3 times 2). All combinations were considered 
in the analysis. A meta-analysis for the revision rate at 10 years was performed. A model for the 
censoring mechanism was employed to reconstruct the data and then a generalized linear mixed 
model with study as a random effect has been applied to estimate the survival at 10 years and its 
confidence interval 20-23. Regarding the RSA studies pooling of migration results at the level of PF 
was based on weights according to study size (N).
Adjustment for confounding 
Since migration data and revision rate data were extracted from different studies, it is possible 
that differences between study populations may confound the observed association. In order to 
address this issue we determined the degree of similarity of the population from RSA and survival 
study combinations, expressed by a match score, for age, gender, diagnosis, hospital type, and 
continent. The match score is constructed according to the results of a recent Delphi among an 
international group of 37 independent experts and can vary between 0 (poor) and 5 (excellent) 
17. The RSA study and survival study combination score 1 point for each of the following criteria 
(up to a maximum of 5 points):
•	 the difference in the mean age between the patients from RSA study and those from 
the survival study was 5 years or less. 
•	 the difference in percentage of females between the RSA study and survival study was 
10% or less. 
•	 the difference in percentage of patients diagnosed with primary osteoarthritis between 
the RSA study and survival study was 10% or less. 
•	 the RSA study and survival study were performed in the similar type of hospital (e.g. 
both university medical centers). 
•	 the RSA study and survival study were performed on the same continent. 
All other cases score zero points.
We used a weighted regression model to assess the association between early migration and 
late aseptic revision corrected for the influence of match score, RSA study quality, survival study 
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Migration thresholds 
According to the principle of “primum non nocere“ (first do no harm), new implant designs 
should perform at least as well as the revision standard of national registries: 3% revision at 
5 years and 5% revision at 10 years according to the Swedish Hip Arthroplasty Registry and 
Australian National Joint Replacement Registry 11,12. Based on this revision standard the following 
three categories were constructed for the phased introduction of new THP: acceptable, at risk 
and unacceptable. The category “acceptable” was defined as the level of migration up to which 
all survival studies have lower revision rates than the standard. The category “ unacceptable” was 
defined as the level of migration from which all revision rates are higher than the standard. The 
category “at risk” is defined as the migration interval between the acceptable and unacceptable 
thresholds, in which studies with revision rates lower and higher than the standard were observed. 
Appraisal of publication bias
We assessed the potential effect of publication bias by comparing the results from the meta-
analysis to the results from national joint registries since they do not suffer from publication bias 
11,12,19. Accordingly, the PF that perform better than average in the meta-analysis should also 
perform better than average in the national joint registries. The same principle also applies to 
PF that perform worse than average. For this purpose the migration pooled by PF was sorted 
according to revision rate pooled by PF and visualized in a dot chart 24.
Results
RSA studies
The literature search yielded 629 hits for the RSA review and 26 studies were included with a 
total of 700 acetabular cups 5,6,25-42. Details on study selection and flow of the review are shown 
in Figure 8.1. The mean AQUILA methodological quality score of the RSA studies was 4.9 (SD 0.8) 
on a 7-point scale. Proximal migration at 2 year was the most frequently and most consistently 
reported migration value: 23 out of 26 RSA studies reported it. Change in inclination (rotation 
around the z-axis) was reported infrequently and inconsistently and did not allow a meaningful 
analysis. All analyses will therefore focus on proximal migration at 2 year.
Survival studies
After the literature search there were 5,290 hits for the survival review and 49 studies were included 
with a total of 38,013 acetabular cups, see Figure 8.1 43-85. The mean AQUILA methodological 
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Figure 8.1 PRISMA flowchart of both reviews. Details of the 13 PF can be found in Table 8.1.
RSA = radiostereometric analysis
THP = total hip prosthesis
FU = follow-up
PF = Prosthesis Fixation 
Early migration and late revision
The matching procedure resulted in 13 different PF and 94 combinations of RSA and survival 
studies, see Table 8.1. There was a clear association between 2 year proximal migration and 
the 10 year revision rate as expressed as prosthesis survival, as shown in Figure 8.2. For every 
millimeter increase in proximal migration (at 2 years) 10% [95% CI 5.5% to 14.2%], p <0.05, 
is added to the 10-year revision rate. Although there was some influence on the results of RSA 
study quality, survival study quality, number of acetabular cups in the RSA study, number of 
acetabular cups in the survival study and match score, the association remained significant (all 
p-values <0.05), see Table 8.2. 
There was no clear association between proximal migration rate (= 2 year proximal migration 
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Figure 8.2 Scatterplot showing association between 2 year proximal migration in mm and revision rate 
for aseptic loosening of the acetabular cup at 10 years in percentages. The colored lines are derived from 
weighted regression according to match quality, survival study quality and RSA study quality (the coeffcients 
and 95%CI are presented in Table 8.2). 
Table 8.1: Prosthesis and Fixation (PF) characteristics.






1 ABG I HA coated 1 8 8
2 Birmingham Hip Resurfacing HA coated 1 4 4
3 Exeter all PE Cement (high viscosity) 2 3 6
4 Harris Galante I Porous coated, screws 2 14 28
5 Harris Galante II Porous coated, screws 1 7 7
6 Link V, threaded Uncoated 1 1 1
7 Omnifit dual radius HA coated 2 1 2
8 Scanhip all PE Cement (high viscosity) 1 3 3
9 Wagner (double) cup Cement 1 1 1
10 Charnley Ogee Cement (high viscosity) 8 3 24
11 Spectron all PE Cement (high viscosity) 1 1 1
12 Lubinus eccentric Cement (high viscosity) 4 2 8
13 Reflection all PE Cement (high viscosity) 1 1 1
Total 26 49 94








































128  |  Chapter 8
Figure 8.3 Scatter plot showing the relation between 2 year proximal migration and revision of the acetabular 
cup for aseptic loosening at 10 years. The thresholds of 0.2 and 1.0mm for the three categories – acceptable; 
at risk; unacceptable - are shown.
Figure 8.4 Dotchart showing the pooled 2 year proximal migration ranked by the pooled 10 year revision 
rate for each PF. The unacceptable PF (based on their migration pattern) have been abandoned with the 
Wagner cup having the worst recorded survival in the Swedish Register 86. A detailed description for each PF 
is available in Table 8.1. R10(%) = pooled revision rate at 10 years follow-up in percentage. NA = not available 
* This a best-case scenario for the Wagner cup, since the reference scene was not made direct postoperatively. 
Hence, the actual 2 year proximal migration is more than the observed value presented here.
** The Birmingham Hip Resurface (BHR) prostheses of the RSA study were implanted by the developer, so the 
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Table 8.2: Association between 2-year proximal migration and revision rate for aseptic loosening at 10 years.
Increase in revision (%) / mm proximal migration 95% CI
Crude 10 5.5 – 14.2
Adjusted for*:
N survival** 4.4 1.1 – 7.7
N RSA** 7.4 3.4 – 11.4
Survival study quality 10.8 6.2 – 15.4
RSA study quality 8.4 4.2 – 12.6
Total Match Score 5.8 2.2 – 9.4
Table 8.2 shows the increase in the 10 year revision (%) for each mm increase in 2-year proximal migration. 
In the crude analysis (unadjusted) 10% [95% CI 5.5% to 14.2%], p <0.05, is added to the 10-year revision 
rate for every mm increase in 2-year proximal migration. 
* When adjusted for e.g. the number of hips in survival studies (N survival) 4.4% [95% CI 1.1% to 7.7%], 
p <0.05, is added to the 10-year revision rate for every mm increase in 2-year proximal migration.
The associated between 2 year proximal migration and revision rate for aseptic loosening remains significant, 
when adjusting for confounders ( all p-values <0.05).
**The square rote of N was used for the weighted regression, so larger studies weigh heavier.
N survival = number of cups in survival studies (survival study size).
N RSA = number of cups in RSA studies (RSA study size).
Migration thresholds
Figure 8.3 shows the three categories for the THP. For proximal migration at 2 years between 0 to 
0.2mm, there was no cup with more than 5% revision for aseptic loosening at 10 years. In case 
of 2-year proximal migration of more than 1.0mm, there was no cup with less than 5% revision 
for aseptic loosening at 10 years. This implies that accepting 5% revision at 10 years resulted in 
a threshold of 0.2mm for acceptable proximal migration at 2 years and a threshold of 1.0mm for 
unacceptable migration proximal migration at 2 years.
Publication bias
The pooled 2-year migration ranked by the pooled 10-year revision rate for each PF is presented 
in Figure 8.4. The Wagner cup and threaded Link V cup were classified as unacceptable based 
of their pooled migration. These cups have been abandoned and are no longer used in today’s 
orthopaedic practice. Moreover, the Wagner cup, has the worst (overall) survival ever recorded 
in the history of the Swedish Register: 28% at 10 years 86. The potential influence of publication 
bias on the unacceptable threshold is therefore small. The 10-year revision rate for the acceptable 
PF were lacking (NA), so longer FU of these PF is necessary to investigate if their 10 year revision 
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Discussion
Results of this systematic review show a clinically relevant association between early proximal 
migration of acetabular cups, as measured with RSA, and clinical failure (i,e, revision surgery) at 
mid term and long term follow-up corrected for, age, gender, diagnosis, type of hospital, region, 
study size and study quality. Each millimeter proximal migration increases the 10 year revision 
rate on average by 10%, which is more than twice the standard revision rate of several national 
joint registries 11,12,19. 
We also found that RSA studies can identify unsafe acetabular cups as early as 2 year post-
operatively. Early identification of these less optimal performing THP with RSA prevents their 
widespread use. Compared to the present policy of introduction of new prostheses, such a policy 
would safeguard numerous patients from potential (extensive) revision surgery with potential 
postoperative comorbidities. 
Strengths of this systematic review are the large number of included studies (75) and patients 
(>38,000), which resulted in 13 different PF. This large variation in PF, which reflects the diversity 
in THP designs and fixation methods, ensures wide applicability of the results. Since migration and 
revision rates are from different studies, the RSA data could not have been used (incorporated) for 
the decision to perform a revision, this means that there is no incorporation bias. 
One limitation is that the migration of the BHR and Omnifit acetabular cups were classified as 
“acceptable”. This means that we expect their 10 year revision rate for aseptic loosening to 
be lower than 5%. However, since their 10-year revision rate was not available in this review, 
longer FU of the BHR and Omnifit is required. Regarding the BHR, it should also be noted that 
the surgery in the RSA study was performed by the developer 27. Thus, the observed migration 
(and “acceptable” classification) does not necessarily apply to non-developers. Regarding the 
Omnifit dual radius cup, it should be noted that although the early migration (primary fixation) is 
classified “acceptable” the problem is secondary loosening due to excessive wear and osteolysis 
34. A phased introduction should therefore also focus on wear measurements, in which RSA could 
play an important role.
We are also aware that RSA only evaluates aseptic loosening while other failure mechanisms (e.g. 
osteolysis and pseudotumors in BHR resurfacing) are not evaluated by RSA. Therefore RSA studies 
are only the first step in the phased introduction as proposed by Malchau 8,87. 
Already more than a decade ago several authors pleaded for a phased evidence-based introduction 
of new prostheses 8,88-90. The observed association between early migration and long term 
revision of acetabular cups translates into practical thresholds values of migration (i.e. RSA) for 
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center RSA studies should be performed to determine the safety of the THP with regard to the 
risk of revision for aseptic loosening and wear. Once the THP is considered safe, phase B studies 
have to be conducted to evaluate the clinical performance of the THP regarding pain relief and 
functioning (clinical scores and patient reported outcome measures (PROMS)) and to determine 
the rate of other complications (e.g. pseudotumors) 87. After release to the market, phase C 
starts where the performance of the THP has to be monitored by post-marketing surveillance in 
national joint replacement registries 10. This includes both the revision rate and patient evaluations 
using patient reported outcome measures (PROMS).
In this systematic review, RSA studies of 10 to 60 patients followed for only 2 year had the same 
conclusion as national joint registries where thousands of patients were followed for 10 years. 
A recent publication has shown a 22% to 35% reduction in the number of revisions of RSA-
tested total knee replacements as compared with non-RSA-tested total knee replacements in the 
national joint registries 91.
Of special interest is the Wagner cup, which has the worst survival ever recorded in the history of 
the Swedish Register: 28% at 10 years 86. If the threshold of unacceptable migration (1.0 mm) 
had been known at the time the Wagner cup was introduced, it would have been classified as 
“unacceptable” after 2 years of RSA follow-up with only eleven patients. The latter would have 
urged a more close follow-up of this prosthesis. The Link V cup would also have been classified 
as “unacceptable” after only 2 years of follow-up with RSA. Both examples illustrate the clinical 
value of the migration thresholds for the early identification of THP with a high likelihood of 
failure at long-term follow-up. 
Various authors and regulatory agencies recognize the potential of RSA 8,13,14,92,93. The NICE 
guidelines of 2003 (United Kingdom) require adequate long-term clinical data for hip prostheses 
and indicate RSA as a promising technique that may be an early warning indicator of expected 
poor long term revision rates 7. The Dutch Orthopaedic Society now requires a phased introduction 
with mandatory RSA-studies before any new hip prosthesis is considered for introduction to the 
Dutch market. 
In conclusion there was a clinically relevant association between early migration of THP and 
late revision for loosening. The proposed migration thresholds can be implemented in a phased 
evidence-based introduction, since they allow early detection of high risk THP while exposing a 
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Methodological concept
To determine the association between early migration and late revision it is necessary to match 
the results from the RSA review to the results of the survival review, because migration data and 
revision rate data are commonly reported in different studies. In other words, since there are very 
few studies directly addressing the relation between early migration of tibial components and late 
revision, it is only possible to study this relation indirectly. 
In medicine, treatment effects can be studied indirectly in so called meta-analyses of indirect 
comparison by comparing two different treatments against a common control1. Results of such 
meta-analyses are usually, but not always, similar to those of meta-analyses of direct comparison 
trials. This mostly depends on whether underlying assumptions are met or not. This will be 
elaborated on further below. The concept of indirect comparison is illustrated in appendix figure 
9.1. Suppose we are interested in the comparison of treatment A versus treatment C yet no 
studies are available that directly compare these two treatments. However, there are studies that 
directly compare treatment A with treatment B (study 1) and treatment C with treatment B (study 
2). Then the estimate of the indirect comparison of treatment A versus C (Tac) is calculated by:
Tac = Tstudy1 - Tstudy 2
or
Tac = Tab - Tbc








































142  |  Chapter 9
Regarding the association between early migration and late revision, the concept is the same as 
that for indirect meta-analyses. However, since we are dealing with an association rather than 
a treatment effect, there is no common control group. Instead, we use the type of Prosthesis, 
Fixation method (e.g. cement or bone ingrowth) and articulating Insert (e.g. modular or non-
modular):, PFI, to match migration with revision rates, as illustrated in appendix figure 9.2. 
Figure 9.2 Indirect comparison of RSA and SUR (survival)
Migration and revision rates are assumed to be a characteristic of a particular type of prosthesis, 
fixation method and articulating insert (PFI). Therefore prosthesis, fixation method and articulating 
insert (PFI) acts similar to the common control group (B) in indirect meta-analyses. 
PFI is defined as an uniquely identifiable tibial component with uniquely identifiable fixation 
method and uniquely identifiable articulating insert. It should be noted that uniquely identifiable 
tibial component is not equal to brand name, as there are multiple tibial components with the 
same brand name. For instance the Miller Galante (MG) was available in at least the following 
different versions:
P F I
MG I, CR, metal backed, 4 pegs, no stem no screws, cemented fixed, modular
MG I, CR, metal backed, 4 pegs, no stem 4 screws, porous-coated fixed, modular
MG II, CR, metal backed, 4 pegs, no stem no screws, cemented fixed, modular
MG II, CR, metal backed, 4 pegs, no stem 4 screws, porous-coated fixed, modular
MG II, CR, metal backed, 4 pegs, no stem 4 screws, HA-coated fixed, modular
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Each of the above versions is considered as a separate PFI. The Miller Galante example also clearly 
illustrates the variation in fixation methods. We distinguished the following fixation methods:




any other type of coating, e.g. HA + tricalcium phosphate (TCP)  
Additionally we considered whether screws were used or not.






Assumption for the indirect method
The validity of the indirect comparison depends on the internal validity (methodological quality) 
and similarity of the included studies1. 
Internal validity
Regarding the internal validity we determined the methodological quality of the RSA studies 
and survival studies according to the AQUILA methodological score2. This score was used as a 
weight in a weighted regression model to assess how it influenced the association between early 
migration and late aseptic revision: studies with higher scores weighed heavier in the analyses. 
Table 7.2 from chapter 7 shows that in the crude analysis the 5 year revision rate increases by 
7.6% for every mm increase in 1-year MTPM. When survival study quality was used as a weight, 
the 7.6% increase/mm 1-year MTPM of the crude analysis changed to 7.4%. So, with survival 
study quality as a weight 7.4% is added to the revision rate for every mm increase in 1-year 
MTPM. When RSA study quality was used as a weight, the 7.6% increase/mm in 1-year MTPM 
of the crude analysis changed to 7.1%. So, with RSA study quality as a weight 7.1% is added to 
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In conclusion internal validity expressed as survival study quality and RSA study quality had a 
small effect on the association between early migration and late aseptic revision and together 
with on average good methodological score for the RSA and survival studies, the requirement of 
adequate internal validity is met.
Similarity
Regarding the similarity (external validity) of the matched RSA and survival studies we determined 
the match score based on similarity in age, gender, diagnosis, hospital type and continent. These 
items and cut off values are based on the results of a recent Delphi among an international group 
of 37 independent experts and were hence determined before the analyses were performed2. 
The match score thus resembles similarity between matching RSA and survival studies and varies 
between 0 and 5 points. A worked example of the calculation of match scores is available further 
below. A higher score indicates greater similarity of the matched RSA and survival study. The 
match score is calculated as follows:
Age
When the difference in mean age between matching RSA and survival study is less than 5 years 
they receive 1 point. When the difference is more than 5 years or unknown (mean age is not 
reported), they receive 0 points.
Gender
When the difference in percentage females between matching RSA and survival study is less 
than 10% they receive 1 point. When the difference is more than 10% or unknown (percentage 
females is not reported), they receive 0 points.
Diagnosis
When the difference in percentage patients with osteoarthritis between matching RSA and 
survival study is less than 10% they receive 1 point. When the difference is more than 10% or 
unknown (percentage patients with osteoarthritis is not reported), they receive 0 points.
Hospital type
The following hospital types were considered: Academic, Developer, Special institute, High 
volume, Public. When the matching RSA and survival study were performed in the same type of 
hospital they received 1 point. When they were performed in different types of hospital or the 








































Methodological considerations on the systematic reviews of chapter 7 and 8  |  145
9
Continent
When the matching RSA and survival study were performed on the same continent they received 
1 point. When they were performed on different continents or the continent was unknown, they 
received 0 points.
The match score was used as a weight in a weighted regression model to assess how it influenced 
the association between early migration and late aseptic revision: studies with higher scores 
weighed heavier in the analyses. 
Table 7.2 from chapter 7 shows that in the crude analysis the 5 year revision rate increases by 
7.6% for every mm increase in 1-year MTPM. When match score was used as a weight, the 7.6% 
increase/mm 1-year migration of the crude analysis remained 7.6%.
In conclusion similarity expressed as match score had almost no effect on the association between 
early migration and late aseptic revision. Therefore the requirement of similarity is met.
Pooling of migration data and survival data
Pooling of migration data and survival data was performed for the appraisal of publication bias: 
the pooled results from the literature were compared with those from the national joint registries, 
since they do not suffer from publication bias. 
Pooling of migration data
Regarding the RSA studies pooling of migration results at the level of PFI was weighed by number 
of tibial components in the RSA study according to the following formula:
Pooled mean1-x = (mean1 * N1 + mean2 * N2 + … + meanx * Nx) / (N1 + N2+ … +Nx)
 
The standard deviation (SD) was pooled according to weighted variation according to the 
following formula:
 
Pooled SD1-x =  sqrt(  (SD1*SD1*(N1-1) + SD2*SD2* (N2-1) + ….+ SDx*SDx*(Nx-1)..) / (N1+N2+… + 
Nx – x)    )
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Pooling of survival data
Starting point for the meta-analysis are the revision rates at 5 years reported in each manuscript 
and the minimum and the maximum follow-up (minFUP, maxFUP) of patients. These quantities may 
be given directly but most often they will need to be estimated from the manuscript by looking 
at dates of accrual (if given) and from the date of submission, or perhaps publication of the 
manuscript. A model for the censoring mechanism based on the minimum and the maximum 
follow-up is assumed here for computing the number at risk and person years for each time. Let 
C(t) be the function that models the censoring mechanism. Based on the available information 
we choose the function C(t) as follows
This function expresses the proportion of patients at time t that have at least t time units of 
follow-up. Given the number of eligible patients (n), the effective number at risk, the number of 
revisions at time j and the number of censored are estimated, respectively, as
Sj: survival at time j
Cj: value of the function C(t) defined in (1) at a specific time j
rj: number at risk at time j
dj: number of deaths at time j
cj: number of censored at time j
This assumes that the censored observations are distributed uniformly over the interval. Under 
the same assumption, from the number of patients at risk ~rj , we can define the number of 
person-years over interval Ij , as rj = Δj(~rj - cj/2), where Δj = tj - tj-1is the length of Ij . Following 
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reconstructed. A Poisson mixed model with study as random effects has been fitted to the 
reconstructed data, to estimate the pooled revision probability and the confidence interval at 5 
years.
Worked example
For this worked example will use the Freeman-Samuelson, metal backed, metal pegs, cemented, 
fixed, modular.
Matching procedure
2 RSA studies met the inclusion criteria3,4 both of them report migration of the Freeman-
Samuelson, metal backed, metal pegs, cemented, fixed, modular.
2 survival studies met the inclusion criteria 5,6 both of them report revision rate of the Freeman-
Samuelson, metal backed, metal pegs, cemented, fixed, modular.
When matching the RSA studies to the survival study we get the following 4 (2 * 2) combinations.
Combi Survival study RSA study
1 Arora 2005 JBJSBr Adalberth 2001 JBJSBr
2 “ Uvehammer 2007 JKneeSurg
3 Robertsson 2000 JBJSBr Adalberth 2001 JBJSBr
4 “ Uvehammer 2007 JKneeSurg
These combinations provide the x-coordinate (migration) and y-coordinate (revision) for the 
figures 7.2 and 7.3 of chapter 7. 






Regarding the similarity (external validity) of the matched RSA and survival studies we determined 
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For example regarding Adalberth 2001 and Arora 2005 the match score is calculated as follows:
age (1 point), because the difference in mean is less than 5 years
gender (0 point), because the difference in % females is more than 10 percent
diagnosis (0 points), because the difference in % OA is more than 10 percent
hospital (1 point), because patients were operated in similar hospital types
continent (1point), both studies are from the same continent
Thus the match score for combi 1 (Adalberth 2001 and Arora 2005) is 1+0+0+1+1 = 3. The 
match scores of combi 1 through 4 are shown below.
Combi age gender Diagnosis Hospital Continent Match score
1 1 0 0 1 1 3
2 1 0 0 1 1 3
3 1 0 0 0 1 2
4 0 0 0 0 1 1
A higher score indicates greater similarity of the matched RSA and survival study. The match score 
was used as a weight in a weighted regression model to assess how it influenced the association 
between early migration and late aseptic revision (see above): therefore in this example combi 1 
and 2 weighed the heaviest, while combi 4 had the lowest weight. 
Pooling of migration data
We will continue with the cemented fixed bearing FS modular to illustrate the pooling of 
migration data.
The data for the 1 year MTPM are:
  mean SD N
Adalberth 2001 :  0.78 0.77 18
Uvehammer 2007 : 0.45 0.38 19
The pooled mean is calculated according to the following formula:
Pooled mean1-x = (mean1 * N1 + mean2 * N2 + … + meanx * Nx) / (N1 + N2+ … +Nx)
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The standard deviation (SD) was pooled according to weighted variation according to the 
following formula:
 
Pooled SD1-x =  sqrt(  (SD1*SD1*(N1-1) + SD2*SD2* (N2-1) + ….+ SDx*SDx*(Nx-1)..) / (N1+N2+… + 
Nx – x)    )
Pooled SD = sqrt ( (0.77*0.77*(18-1) + 0.38*0.38*(19-1)) / (18 +19 -2) ) = sqrt ( (10.1 + 2.60) / 
35) = sqrt (0.362) = 0.60
With a pooled mean of 0.61mm a pooled SD of 0.60 and Ntotal of 37 the 95% confidence interval 
becomes:
0.42mm to 0.80mm
Pooling of survival data
The pooled 5 year revision of the cemented fixed bearing FS modular uses the revision rates from 
the 2 included studies (see above). The pooled 5 year revision aseptic loosening was 2% for the 
cemented fixed bearing FS modular as is shown in figure 7.5 of chapter 7.
Details of the literature search strategy
RSA studies
PubMed: (“Photogrammetry”[Mesh] OR “roentgen stereophotogrammetric analysis” OR rsa OR 
radiostereometr* OR stereophotogrammetr* OR “roentgen fluoroscopic”) 
AND 
(“Joint Prosthesis”[Mesh] OR hip prosthesis OR knee prosthesis OR TKA OR THA OR THR OR TKR 
OR “joint replacement” OR Arthroplasty, Replacement[mesh] OR “total knee replacement” OR 
“total hip replacement”)
Survival cohort studies
PubMed: (“Joint Prosthesis”[Mesh] OR hip prosthesis OR knee prosthesis OR TKA OR THA 
OR THR OR TKR OR “joint replacement” OR Arthroplasty, Replacement[mesh] OR “total knee 
replacement” OR “total hip replacement”) 
AND 
(“Prosthesis Failure”[Mesh] OR “prosthetic loosening” OR “aseptic loosening” OR “implant 
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AND 
(“survival analysis”[MeSH Terms] OR (“survival”[All Fields] AND “analysis”[All Fields]) OR “survival 
analysis”[All Fields] OR cohort studies[mesh] OR “follow up” OR “follow-up” OR experience OR 
outcome)
These strings were adapted to fit the vocabulary of the other databases mentioned above.
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General Discussion
The aim of this thesis is to evaluate the clinical value of migration measured with RSA in TKP and 
THP. The first aim was on the association of short term (two year) migration and the likelihood 
for long term (10 year) revision for aseptic loosening. The latter is important in the context of 
a phased introduction of new TKP and THP. The second aim was on the long term migration 
patterns of different types of fixation (i.e. cemented and cementless) of different types of TKP 
as part of a post-marketing surveillance with RSA. In this general discussion of my thesis I will 
address the strengths and limitations of the clinical value of RSA as well as future perspectives. 
10.1 Proof of concept
The association between short-term RSA results and future loosening of TKP and THP has been 
previously studied, but the effect of pre-market testing with RSA on the revision burden remains 
unknown.1-4 A phased evidence based introduction of new TKP and THP does not yet exist. At 
present, most new TKP and THP designs are approved and distributed on the market without 
extensive safety and effectiveness testing via the 510(k) pathway in the US and regulation via 
notified bodies in Europe (Directive 93/42/EEC) .5,6 Both the 510(k) pathway in the US and the 
reviews of device reliability via notified bodies in Europe have created an environment in which 
unsafe TKP and THP can reach the market.7
Nevertheless, even in the absence of a formal phased introduction RSA studies that show high 
migration for a particular TKP or THP may result in discontinuing the implantation and production 
of that TKP and THP. This was for instance the case with the uncoated uncemented Interax 
TKP.8 Once identified such high risk implants could be taken off the market in an early stage 
preventing widespread introduction and subsequent large numbers of revisions. This effect 
should be detectable in the national joint registries given there has been sufficient time to make 
decisions based upon the results of RSA studies. Considering that clinical RSA studies have been 
conducted for over 35 years, there has indeed been sufficient time to draw conclusions and 
make those decisions.9 In chapter 2 the revision rates of TKP with RSA testing and without RSA 
testing were determined in the national joint registries of Sweden, Australia and New Zealand. 
In case an RSA study was performed for a particular TKP there was a 22% to 35% reduction in 
the number of revisions (any reason) compared to TKP without RSA testing. It should be noted, 
however, that RSA testing focuses on the risk of revision for aseptic loosening, while the registries 
reported revision for any reason. Another limitation to be considered is the notion that registries 
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pegs or stem; cruciate retaining or posterior stabilized). Nevertheless the phenomenon that TKP 
with RSA testing have lower revision rates than TKP without RSA testing is a proof of concept 
to demonstrate the feasibility of pre-market RSA testing of new TKP and THP in the context of a 
phased evidence-based introduction.
10.2 Generalizability
When the phased evidence based introduction of new TKP and THP would come into effect, the 
decision whether to allow a prosthesis onto the market or not, will ideally depend on a small 
number of studies with as few patients as possible.10,11 Small study size (n= 20 to n= 60)12 will 
minimize the patients put at risk and a small number of studies will reduce the time needed to 
make a decision for market approval, because consecutive studies would postpone the final 
decision. The question could then be raised whether the results from this small number of studies 
can be generalized.13 In other words, do the results from those studies apply to other institutions 
with different patient populations (e.g different. age or pre-operative diagnosis) and different 
regional influences (e.g. differences in experience of the surgeon or type of hospital) ? And do 
they apply to the rest of the world? Chapter 3 and 6 dealt with this external validity. Chapter 3 
was a systematic review that evaluated whether the prediction of implant performance as studied 
in a previous RSA trial, published in 1998, was correct.8 The results of that RSA trial by Nelissen et 
al. showed that the uncoated Interax tibial components had increased early migration compared 
to HA-coated and cemented tibial components.8 Since these uncoated components had shown 
the highest migration, it was predicted that this type of fixation would have a high failure rate.2,3 
In the systematic review two studies were included from other institutions (one German and 
one French) with patient populations that were rather different from the RSA trial by Nelissen et 
al.14,15 When the results of these studies were combined in a meta-analysis, the high revision rate 
in the uncoated components became clearly visible. Furthermore, high migration of the uncoated 
Interax tibial components has also been demonstrated by Østgaard et al.16 Their migration results 
were very similar to those of Nelissen et al despite differences in patient characteristics: all their 
patients were suffering from osteoarthritis, compared to 30% osteoarthritis and 70% rheumatoid 
arthritis in the study by Nelissen et al.8,16 Although these findings plead strongly in favour of 
generalizability of RSA results beyond the study they were investigated in, it should be noted that 
the number of studies that actually confirm this at the level of prosthesis design is still limited.4 
Even though the results from RSA studies appear to be applicable beyond the study they 
were studied in, it would still be helpful to identify what factors are relevant for generalizing 
the results. Identification of these factors would help answering the question if and to what 
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new TKP and THP would apply to other institutions (i.e. the rest of the world). In chapter 6 
factors relevant for generalizability were identified by a group of 37 international experts through 
a Delphi procedure: AQUILA initiative. Consensus was reached on factors comprising patient 
demographics, component positioning, post-operative functioning and regional influences 
including type of institution (e.g. developer, academic or regional hospital). It would therefore 
be prudent that studies performed during a phased evidence based introduction of a new TKP 
and THP include a wide range of these generalizability factors to ensure wide applicability of the 
results. Since the majority of TKP and THP, if approved for the market, will be implanted by non-
developer surgeons it is equally important that those pre-marketing studies are performed by the 
non-developer surgeons.
10.3 Early migration and late revision for aseptic loosening
The evidence for the relation between early (two year) migration and late (10 year) failure of TKP 
and THP by aseptic loosening, has been studied by Grewal, Ryd,, Kärrholm, Nieuwenhuijse and 
Hauptfleish.1-4,17 The systematic reviews in chapter 7 and 8 confirm the results of these studies. 
Chapter 7 was a systematic review that demonstrated a clear and clinically relevant association 
between early migration (expressed as MTPM at 1 year) of tibial components, as measured 
with RSA, and clinical failure (i,e, revision surgery) at mid term and long term follow-up, which 
remained after correction for, age, gender, diagnosis, type of hospital, region, study size and study 
quality. Equally, chapter 8 showed that 2 year proximal migration of acetabular components was 
associated with revision surgery for aseptic loosening at long term follow-up. This association 
also remained after correction for age gender, diagnosis, type of hospital, region, study size and 
study quality. MTPM at 1 year and proximal migration at 2 year were chosen because they were 
reported most often and most consistently. However this does not imply that these migration 
parameters and follow-up are optimal. Further research is needed to determine the optimal 
migration parameter and follow-up. Such research would consist of large RSA cohorts followed 
for 10 years or more to determine the optimal migration parameters to predict loosening. For the 
present MTPM at 1 year can be used for early detection of unsafe TKP (tibial components) that are 
at risk for high revision rates and proximal migration at 2 year can be used for the early detection 
of unsafe acetabular cups. These migration parameters for a new to be introduced TKP or THP 
can be determined in multiple centers worldwide to substantiate the evidence. However, when 
these migration parameters are used in the context of a phased evidence based introduction one 
should recognize the fact that RSA only evaluates aseptic loosening. Futhermore, new TKP and 
THP may introduce new failure mechanisms (e.g. pseudotumors in hip resurfacing).18 These failure 
mechanisms are not detected by RSA and require additional steps in the phased introduction as 
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10.4 Standardization of outcome reporting
It is generally accepted that reporting guidelines such as CONSORT, STARD en STROBE (including 
the diseases specific extension AQUILA) have an important role in improving the accuracy, 
completeness and quality of clinical studies.19-23 For RSA studies an additional guideline has been 
developed for terminology, description, use of RSA arrangement including radiographic set-up 
and techniques and among others describing of prosthetic migration.24 However, in chapters 
7 and 8 it became apparent that RSA studies could benefit from further improvement in the 
reporting of migration results. Future updates of the systematic reviews from chapter 7 and 
8 in particular would greatly benefit from standardized and complete reporting of prosthetic 
migration: mean migration (minimum requirements MTPM for TKP and proximal migration and 
change in inclination for cups), the number of RSA examinations and standard deviation for each 
type of prosthesis at each follow-up moment and detailed description of the type of prosthesis 
and fixation method. 
10.5 Post-market surveillance
After release to the market the performance of the TKP and THP should be monitored by post-
marketing surveillance in national joint replacement registries.10,11,25 This includes both the revision 
rate and patient evaluations using patient reported outcome measures (PROMS). In addition to 
the registries, post-marketing studies as well as long term follow up of the pre-marketing studies 
could prove valuable similar to post-marketing surveillance in pharmaceuticals10,11,25-27 Since the 
pre-marketing studies have the longest available follow-up, these studies would be the first to 
detect long term problems and complications. On the other hand they could also provide further 
evidence for the conclusions made on the early results. For instance the study by Nelissen et al 
demonstrated that hydroxyapatite (HA) significantly reduced the early migration of uncemented 
tibial components in TKA.8 Chapter 4 evaluated the long term result of the Nelissen trial. The study 
results indicated that HA significantly reduces migration compared to the uncoated components 
and that this effect endured beyond 10 years. Moreover, any negative effects of HA, such as 
delamination of the HA layer and third body wear due to HA-particles, were not observed.28,29 
Furthermore there were two cases among the revisions that were of particular interest, because 
of their migration pattern. The tibial components of these cases started to migrate after a period 
of stability. Such failure mechanism has not yet been observed with RSA and is different from that 
described by Ryd consisting of continuous migration that eventually requires revision.2 
In Chapter 5 the 10 to 12 year fixation of mobile bearing (MB) TKP was compared to fixed bearing 
(FB) TKP in a best case setting. The results showed that even in a best case setting (better quality 
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advantage over the FB in terms of long term migration. These results are in accordance with the 
conclusions from several recent meta-analyses that found no difference in clinical and radiological 
scores between MB and FB.30-33 In chapter 5 it was also possible to determine the backside wear 
rate of the mobile bearings with RSA: 0.026 mm/ year. The backside wear underneath the mobile 
bearing was small and may not be of clinical relevance.
10.6 Future perspectives
A phased evidence based introduction of new TKP and THP does not yet exist, see Table 10.1. 
At present, most new TKP and THP designs are approved and distributed on the market without 
extensive safety and effectiveness testing via the 510(k) pathway in the US and via notified bodies 
in Europe (Directive 93/42/EEC) .5,6 Future phases of a phased clinical introduction of new total 
knee and total hip implants include RSA studies and larger multicenter studies as indicated in 
Table 10.1.
Table 10.1: Present and future phases of a phased clinical introduction of new total knee and total hip 
implants. Note that after successful introduction to the market, the implant needs post-market surveillance 
in national implant registries. 
1 Pre clinical (bench) testing (501k pathway)36
Present2 Mandatory clinical studies (CE class III, Directive 93/42/EEC and Directive 
2005/50/EC; Premarket approval application (PMA))5,7,37,38
3 RSA studies for evaluation of migration and wear
Future
4 Larger multicenter studies to evaluate
pain relief, functioning (clinical
scores and patient-reported outcome measures (PROMS)) and the rate
of expected or unexpected complications by labaratory studies (Co Cr 
levels), osteolysis and pseudotumours by CT or MRI
It is already possible to measure measurement of polyethylene wear in TKP and THP with great 
accuracy.34 The accuracy of this technique has been reported by Ijsseldijk et al to be 0.1mm with 
a precision of 0.2mm for the linear wear measurements in TKP.34 However there are no clear 
thresholds of wear at 1 or 2 years follow-up that predict long term polyethylene (PE) failure and 
wear related revisions. Therefore further research is needed to evaluate how these high precision 
early wear measurements relate to long term polyethylene (PE) wear and related revisions before 
such measurements can be implemented in the phased evidence introduction of new TKP and 
THP. Nevertheless, eventual implementation of this technique would mean that both early 
migration and PE wear can be measured in the same patient group maximizing efficiency and 
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In the light of a phased clinical introduction of new implants it is of paramount importance to 
register RSA studies (including case series and cohorts) e.g. at clinicaltrials.gov before start of the 
study and data-analysis, as is common practice for randomized controlled trials. Although study 
registration is not yet compulsory for RSA cohorts and case-series, proper study registration of 
such studies would ensure assessment of publication bias especially when the migration of new 
prostheses exceed the unacceptable thresholds. Future RSA research will greatly benefit from 
further standardisation by ISO standards and reporting guidelines for outcomes. 
Early detection of migration allows early (re)fixation of loosened implants, which hold great 
promise for the future.35
Finally, a future RSA data network (i.e. registry) would be extremely useful to exchange knowledge 
and to combine data, so that research questions that require greater diversity or a larger sample 
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Summary
The aim of this thesis is to evaluate the clinical value of migration measured with RSA in TKP and 
THP. The first aim was on the association of short term (two year) migration and the likelihood 
for long term (10 year) revision for aseptic loosening. The latter is important in the context of 
a phased introduction of new TKP and THP. The second aim was on the long term migration 
patterns of different types of fixation (i.e. cemented and cementless) of different types of TKP as 
part of a post-marketing surveillance with RSA. 
Chapter 2 RSA and registries: the quest for phased introduction of new implants 
In this chapter the predictive power of RSA was evaluated within a two-year follow-up after 
arthroplasty and its relationship to national joint registries. For this purpose the association 
between RSA prosthesis-migration data and registry data was studied. The five-year rate of 
revision of RSA-tested total knee replacements was compared with that of non-RSA-tested total 
knee replacements. Data were extracted from the published results of the national joint registries 
of Sweden, Australia, and New Zealand. There was a 22% to 35% reduction in the number of 
revisions of RSA-tested total knee replacements as compared with non-RSA-tested total knee 
replacements in the national joint registries. Assuming that the total cost of revision total knee 
arthroplasty is $37,000 in the United States, a 22% to 35% reduction in the number of revisions 
(currently close to 55,000 annually) could lead to an estimated annual savings of over $400 
million to the health-care system. The phased clinical introduction of new prostheses with two-
year RSA results as a qualitative tool could lead to better patient care and could reduce the costs 
associated with revision total knee arthroplasty. Follow-up in registries is necessary to substantiate 
these results and to improve post-market surveillance.
Chapter 3 RSA prediction of high failure rate for the uncoated Interax TKA confirmed 
by meta-analysis 
In a previous radiostereometric (RSA) trial the uncoated, uncemented, Interax tibial components 
showed excessive migration within 2 years compared to HA-coated and cemented tibial 
components. It was predicted that this type of fixation would have a high failure rate. The 
purpose of the systematic review and meta-analysis in chapter 3 was to investigate whether this 
RSA prediction was correct. A systematic review and meta-analysis was performed to determine 
the revision rate for aseptic loosening of the uncoated and cemented Interax tibial components. 
3 studies were included, involving 349 Interax total knee arthroplasties (TKAs) for the comparison 
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components. There was a 3-times higher revision rate for the uncoated Interax components than 
that for cemented Interax components (OR = 3; 95% CI: 1.4-7.2). This meta-analysis confirmed 
the prediction of a previous RSA trial. The uncoated Interax components showed the highest 
migration and turned out to have the highest revision rate for aseptic loosening. RSA appeared 
to enable efficient detection of an inferior design as early as 2 years postoperatively in a small 
group of patients.
Chapter 4 The beneficial effect of hydroxyapatite lasts: a randomized radiostereometric 
trial comparing hydroxyapatite-coated, uncoated, and cemented tibial components for 
up to 16 years
In contrast to early migration, the long-term migration of hydroxyapatite- (HA-) coated tibial 
components in TKA has been scantily reported. The randomized controlled trial in chapter 4 
investigated the long-term migration measured by radiostereometric analysis (RSA) of HA-coated, 
uncoated, and cemented tibial components in TKA. 68 knees were randomized to HA-coated 
(n = 24), uncoated (n = 20), and cemented (n = 24) components. All knees were prospectively 
followed for 11-16 years, or until death or revision. RSA was used to evaluate migration at 
yearly intervals. Clinical and radiographic evaluation was according to the Knee Society system. 
A generalized linear mixed model (GLMM, adjusted for age, sex, diagnosis, revisions, and BMI) 
was used to take into account the repeated-measurement design. The present study involved 742 
RSA analyses. The mean migration at 10 years was 1.66 mm for HA, 2.25 mm for uncoated and 
0.79 mm for the cemented group (p < 0.001). The reduction of migration by HA as compared 
to uncoated components was most pronounced for subsidence and external rotation. 3 tibial 
components were revised for aseptic loosening (2 uncoated and 1 cemented), 3 for septic 
loosening (2 uncoated and 1 cemented), and 1 for instability (HA-coated). 2 of these cases were 
revised for secondary loosening after a period of stability: 1 case of osteolysis and 1 case of late 
infection. There were no statistically significant differences between the fixation groups regarding 
clinical or radiographic scores. HA reduced migration of uncemented tibial components. This 
beneficial effect lasted for more than 10 years. Cemented components showed the lowest 
migration. Longitudinal follow-up of TKA with RSA allows early detection of secondary loosening.
Chapter 5 Differences in long-term fixation between mobile-bearing and fixed-bearing 
knee prostheses at ten to 12 years’ follow-up: A single-blinded randomised controlled 
radiostereometric trial
The single-blinded randomised controlled trial in chapter 5 investigated whether one design of 
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design on long-term fixation as measured by radiostereometry. The amount of wear underneath 
the mobile bearing was also evaluated. A series of 42 knees was randomised to MB or FB tibial 
components with appropriate polyethylene inserts and followed for between ten and 12 years, 
or until the death of the patient. The polyethylene in the MB group was superior in that it 
was gamma-irradiated in inert gas and was calcium-stearate free; the polyethylene in the FB 
group was gamma-irradiated in air and contained calcium stearate. In theory this should be 
advantageous to the wear rate of the MB group. At final follow-up the overall mean migration 
was 0.75 mm (sd 0.76) in the MB group and 0.66 mm (sd 0.4) in the FB group, with the FB group 
demonstrating more posterior tilt and the MB group more internal rotation. In the FB group there 
was one revision for aseptic loosening, but none in the MB group. There were no significant 
differences in clinical or radiological scores. For the MB group, the mean linear wear rate on the 
under-surface was 0.026 mm/year (sd 0.014). This was significantly smaller than the wear rate 
of 0.11 mm/year (sd 0.06) in the MB between femur and polyethylene (p < 0.001). Nevertheless, 
even in a best-case setting the mobile bearings of this TKR design had no apparent advantage in 
terms of fixation over the FB knee prosthesis at ten to 12 years. The wear underneath the mobile 
bearing was small and is unlikely to be clinically relevant.
Chapter 6 AQUILA: assessment of quality in lower limb arthroplasty. An expert Delphi 
consensus for total knee and total hip arthroplasty 
In this chapter a Delphi approach was used to develop a checklist for reporting quality, 
methodological quality and generalizability of case series and cohorts in total hip and total knee 
arthroplasty with a focus on aseptic loosening. The web-based Delphi consisted of two internal 
rounds and three external rounds. The internal rounds were used to construct a master list. The 
first external round was completed by 44 external experts, 35 of them completed the second 
external round and 33 of them completed the third external round. Consensus was reached on an 
8-item reporting quality checklist, a 6-item methodological checklist and a 22-item generalizability 
checklist. Checklist for reporting quality, methodological quality and generalizability for case 
series and cohorts in total hip and total knee arthroplasty were successfully created through this 
Delphi. These checklists should improve the accuracy, completeness and quality of case series and 
cohorts regarding total hip and total knee arthroplasty.
Chapter 7 Early migration of tibial components is associated with late revision 
A systematic review and meta-analysis of 21,000 knee arthroplasties
In this chapter two parallel systematic reviews and meta-analyses were performed to determine 








































Summary and General discussion  |  167
10
review comprised early migration data from radiostereometric analysis (RSA) studies, while the 
other focused on revision rates for aseptic loosening from long-term survival studies. Thresholds 
for acceptable and unacceptable migration were determined according to that of several national 
joint regis tries: < 5% revision at 10 years. Following an elaborate literature search, 50 studies 
(involving 847 total knee prostheses (TKPs)) were included in the RSA review and 56 studies 
(20,599 TKPs) were included in the survival review. The results showed that for every mm increase 
in migration there was an 8% increase in revision rate, which remained after correction for age, 
sex, diagnosis, hospital type, continent, and study quality. Con sequently, migration up to 0.5 
mm was considered acceptable during the first postoperative year, while migration of 1.6 mm 
or more was unacceptable. TKPs with migration of between 0.5 and 1.6 mm were considered 
to be at risk of having revision rates higher than 5% at 10 years. In conclusion, there was a 
clinically relevant association between early migration of TKPs and late revision for loosen ing. The 
proposed migration thresholds can be implemented in a phased, evidence-based introduction of 
new types of knee pros theses, since they allow early detection of high-risk TKPs while exposing 
only a small number of patients.
Chapter 8 Early proximal migration of cups is associated with late revi sion in THA 
A systematic review and meta-analysis of 26 RSA studies and 49 survival studies
In this chapter two parallel systematic reviews and meta-analyses were performed to determine 
the association between early migration of acetabular cups and late aseptic revision. One review 
covered early migration data from radiostereometric analysis (RSA) studies, while the other 
focused on revision rates for aseptic loosening from long-term survival studies. Thresholds for 
acceptable and unacceptable migration were classified according the Swedish Hip Arthroplasty 
Register and the Australian National Joint Replacement Registry: < 5% revision at 10 years. 
Following an elaborate literature search, 26 studies (involving 700 cups) were included in the RSA 
review and 49 studies (involving 38,013 cups) were included in the survival review. For every mm 
increase in 2-year proximal migration, there was a 10% increase in revision rate, which remained 
after correction for age, sex, diagnosis, hospital type, continent, and study quality. Consequently, 
proximal migration of up to 0.2 mm was considered acceptable and proximal migration of 1.0 
mm or more was considered unacceptable. Cups with proximal migration of between 0.2 and 
1.0 mm were considered to be at risk of having revision rates higher than 5% at 10 years. In 
conclusion, there was a clinically relevant association between early migration of acetabular cups 
and late revision due to loosening. The proposed migration thresholds can be implemented in 
a phased evidence-based introduction, since they allow early detection of high-risk cups while 
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Discussion and Conclusion
At present, most new TKP and THP designs are approved and distributed on the market without 
extensive safety and effectiveness testing via the 510(k) pathway in the US and via notified bodies 
in Europe (Directive 93/42/EEC) .1,2 This practice has created an environment in which unsafe TKP 
and THP can reach the market.3
It has become increasingly evident that a phased evidence-based introduction, which is common 
for pharmaceuticals, is needed to regulate the introduction of new TKP and THP to the market. 
This would allow monitoring of the safety and quality of TKP and THP to prevent harm to patients 
and to minimize costs to society (i.e. reduction of the future revision burden).
The studies in this thesis show that RSA studies can identify unsafe (i.e. high failure rates due 
to loosening) TKP and THP as early as 2 years postoperatively. Early identification of these less 
optimal performing TKP and THP with RSA prevents their widespread use.
The phased clinical introduction of new prostheses with two-year RSA results as a qualitative 
tool could lead to better patient care and could reduce the costs associated with revision surgery. 
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Het doel van deze thesis is het onderzoeken van de klinische waarde van migratie van totale 
knie protheses (TKP) en totale heup protheses (THP) gemeten met Radiostereometrische Analyse 
(RSA). Het eerste doel is om de associatie te onderzoeken tussen vroege migratie en late revisie 
voor aseptische loslating in de context van een gefaseerde klinische introductie voor nieuwe TKP 
en THP. Het tweede doel is om de lange termijn migratie te bepalen van verschillende type TKP en 
verschillende fixaties in de context van post-markering surveillance met RSA.
Hoofdstuk 2 RSA en registers: de zoektocht naar gefaseerde introductie van nieuwe 
implantaten
In dit hoofdstuk werd de vroeg (2 jaar) voorspellende waarde van RSA voor revisie van 
gewrichtsimplantaten onderzocht. Hiervoor werd de associatie tussen migratie van de prothese, 
gemeten met RSA, en revisie percentages uit nationale implantaten registers bestudeerd. Het 
5-jaar revisie percentage van RSA-geteste totale knie protheses (TKP) werd vergeleken met dat 
van niet-RSA-geteste TKP. De gegevens werden geëxtraheerd uit de gepubliceerde resultaten van 
de nationale implantaten registers van Zweden, Australië en Nieuw Zeeland. Uit de gegevens van 
de nationale implantaten registers bleek een reductie van 22% tot 35% in het aantal revisies 
voor RSA-geteste TKP vergeleken met de niet-RSA-geteste TKP. Aangenomen dat in de Verenigde 
Staten de totale kosten voor een revisie van een TKP $37,000 bedragen, kan een reductie in het 
aantal revisies van 22% tot 35% oplopen tot een besparing van $400 miljoen per jaar in de zorg 
in de VS. De gefaseerde klinische introductie van nieuwe implantaten op basis van RSA studies 
met 2 jaar follow-up kan leiden tot betere patiëntzorg en tot een reductie van de kosten in de 
zorg ten gevolge van revisie van TKP. Follow-up in nationale implantaten registers is noodzakelijk 
om de resultaten van de implantaten te blijven vervolgen, nadat deze op de markt zijn gekomen. 
Hoofdstuk 3 Voorspelling van hoog revisie percentage voor de ongecoate Interax TKP 
bevestigd door meta-analyse
Uit eerder gerandomiseerd onderzoek bleek dat 2 jaar post-operatief de ongecoate, 
ongecementeerde Interax tibiale componenten excessief veel migreerden vergeleken met 
de hydroxyapatite (HA)-gecoate en gecementeerde tibiale componenten. Op basis van dit 
resultaat werd een hoog revisie percetage voor de ongecoated Interax TKP voorspeld. Het doel 
van de systematische review en meta-analyse in hoofdstuk 3 is om te onderzoeken of deze 
RSA voorspelling klopt. Er werd een systematische review en meta-analyse gedaan naar het 
revisie percentage voor aseptische loslating van de ongecoate en gecementeerde Interax tibiale 
componenten. Drie studies werden geincludeerd met in totaal 349 TKP van het Interax type. Er 
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in een 3 keer zo hoog revisie percentage voor de ongecoate Interax componenten vergeleken 
met de gecementeerde componenten (OR = 3; 95% CI: 1.4-7.2). Deze meta-analyse bevestigd 
de voorspelling van de RSA studie uit 1998: de ongecoate Interax componenten migreerden het 
meeste en hadden het hoogste revisie percentage voor aseptische loslating. Met RSA was het 
dus mogelijk om een inferieur type TKP vroeg post-operatief (2 jaar) te identificeren in een kleine 
groep patiënten. 
Hoofdstuk 4 Het gunstige effect van hydroxyapatite (HA) persisteert: een gerandomiseerd 
radiostereometric onderzoek van HA-gecoate, ongecoate en gecementeerde tibiale 
componenten tot 16 jaar follow-up
In tegenstelling tot vroege migratie is de lange termijn migratie van HA-gecoate tibiale 
componenten van totale knie protheses nauwelijks gerapporteerd in de literatuur. Het doel van 
deze geblindeerde, gerandomiseerde studie was om te onderzoeken hoe drie verschillende type 
fixaties de lange termijn migratie van totale knie protheses beïnvloeden.
68 knieën werden gerandomiseerd tot hydroxyapatite (HA) gecoate, ongecoate of gecementeerde 
componenten en prospectief gevolgd voor 11-16 jaar, of tot revisie van de prothese of dood 
van de patiënt. Met behulp van Radiostereometrische Analyse (RSA) werd jaarlijks de migratie 
bepaald. Klinische en radiologische evaluatie vond plaats volgens het systeem van The Knee 
Society. Een lineair mixed effect model (GLMM) werd gebruikt voor de statistische analyse 
vanwege de herhaalde metingen en om voor leeftijd, geslacht, diagnose, revisies en BMI te 
corrigeren. In totaal werden er 759 RSA analyses verricht. De gemiddelde migratie op 10 jaar was 
1.66mm voor HA-gecoate, 2.25mm voor ongecoate en 0.79mm voor de gecementeerde groep (p 
< 0.001). De afname in migratie door HA, vergeleken met de ongecoate componenten, was het 
meest uitgesproken voor inzakking en exorotatie van de componenten. Drie tibiale componenten 
waren gereviseerd voor aseptische loslating (2 ongecoate en 1 gecementeerde), 3 voor septische 
loslating (2 ongecoate en 1 gecementeerde) en 1 voor instabiliteit (HA-gecoate). Twee van deze 
componenten werden gereviseerd voor secundaire loslating na een periode van stabiliteit: 1 geval 
van osteolyse en 1 geval van late infectie. Wat betreft klinische en radiologische uitkomstmaten 
waren er geen klinisch relevante of statistisch significante verschillen tussen de fixatie groepen. 
HA bewerkstelligde een significante reductie op de migratie en dit gunstige effect was op 10 jaar 
nog steeds aanwezig. Gecementeerde componenten migreerden het minste. Het is mogelijk om 








































Nederlandse Samenvatting  |  175
N
Hoofdstuk 5 Verschillen in lange termijn fixatie tussen totale knie prothesen met 
beweegbaar lager en vast lager 10 tot 12 jaar post-operatief: een enkel geblindeerd 
gerandomiseerd radiostereometrisch onderzoek
Het doel van dit hoofdstuk was om te onderzoeken of een bepaald type TKP met beweegbaar 
lager voordelen heeft ten opzichte van een vast lager wat betreft de lange termijn fixatie als 
gemeten met RSA. De mate van slijtage aan de onderkant van het beweegbaar lager werd ook 
gemeten. Een serie van 42 knieën werd gerandomiseerd tot een TKP met beweegbaar of vast 
lager en gevolgd voor 10-12 jaar of tot revisie van de prothese of dood van de patiënt. Het 
polyethylene van de beweegbare lagers (gamma-bestraald in inert gas en vrij van calcium-stearaat) 
was superior aan dat van de vaste lagers (gamma-bestraald in lucht en bevat calcium-stearaat). 
Dit zou theoretisch in het voordeel zijn voor de beweegbare lagers. Bij de laatste follow-up was 
de gemiddelde migratie 0.75mm (sd 0.76) voor de beweegbare lagers en 0.66mm (sd 0.4) voor 
de vaste lagers. Er was meer posterieure tilt bij de vaste lagers en meer interne rotatie bij de 
beweegbare lagers. In de vaste lager groep vond 1 revisie plaats voor aseptische loslating versus 
geen revisie voor aseptische loslating in de beweegbare lager groep. Wat betreft klinische en 
radiologische uitkomstmaten waren er geen klinisch relevante of statistisch significante verschillen 
tussen de groepen. De gemiddelde lineaire slijtage aan de onderkant van de beweegbare lager 
was 0,026mm per jaar (sd 0,014). Dit was significant kleiner dan de slijtage van 0,11mm per 
jaar (sd 0,06) aan de bovenkant van de beweegbare later (p<0.001). Zelfs met superior PE van 
de beweegbare lagers hadden deze geen evidente voordeel ten opzichte van de vaste lagers 
wat betreft lange termijn fixatie. De slijtage aan de onderkant van de beweegbare lagers was 
minimaal en waarschijnlijk niet klinisch relevant.
Hoofdstuk 6 AQUILA: assessment of quality in lower limb arthroplasty. Een Delphi 
concensus van experts van totale knie en totale heup protheses 
In dit hoofdstuk werd door middel van een Delphi proces een checklist ontwikkeld voor rapportage 
kwaliteit, methodologische kwaliteit en generaliseerbaarheid van case series en cohorten in totale 
knie (TKP) en totale heup prothesiologie (THP) met focus op aseptische loslating. 
De web-based Delphi bestond uit twee interne rondes en drie externe rondes. Tijdens de interne 
rondes werd een master lijst gecreëerd, welke de basis vormde voor de externe rondes. De eerste 
externe ronde werd voltooid door 44 externe experts, van wie 35 ook de tweede en 33 ook de derde 
ronden voltooiden. Er werd consensus bereikt op een 8-item rapportage kwaliteit checklist, een 
6-item methodologische kwaliteit checklist en een 22-item checklist voor generaliseerbaarheid. 
Deze checklists dragen bij aan de verbetering van de nauwkeurigheid, volledigheid en kwaliteit 
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Hoofdstuk 7 Vroege migratie van tibiale componenten is geassocieerd met late revisie. 
Een systematische review en meta-analyse van 21.000 totale knie protheses 
In dit hoofdstuk werden de resultaten gepresenteerd van twee parallelle systematische reviews en 
meta-analyses naar de associatie tussen vroege migratie van tibiale componenten en late revisie. 
Een review omvatte vroege migratie waardes van RSA studies, terwijl de andere review revisie 
percentages aseptische loslating uit lange termijn survival studies betrof. 
Uitgaande van verscheidene nationale implantaten registers waren revisie percentages van 5% 
op 10 jaar als standaard gekozen. Na de inclusie procedure bleven er 56 survival studies (20.559 
TKPs) over en 50 RSA studies (847 TKPs). Er bleek een significante associatie tussen vroege 
migratie en late revisie percentage: voor elke millimeter migratie nam het revisie percentage toe 
met 8%, hetgeen significant bleef na correctie voor leeftijd, geslacht, diagnose, type ziekenhuis, 
continent en studie kwaliteit. Migratie van minder dan 0,5mm op 1 jaar was acceptabel. Een 
overschrijding van 1,6mm op 1 jaar was onacceptabel. Als de migratie tussen de 0,5 en 1,6mm 
lag was het type prothese “at risk” voor revisie hoger dan de 5% 10-jaars revisiestandaard. 
Concluderend, met de voorgestelde migratie drempelwaardes was het mogelijk om onveilige TKP 
vroeg te identificeren in een kleine groep patiënten. TKP surveillance met de drempelwaardes kan 
passen in een gefaseerde klinische introductie voor nieuwe totale knie prothesen.
Hoofdstuk 8 Vroege proximale migratie van cups is geassocieerd met late revisie in THP. 
Een systematische review en meta-analyse van 26 RSA studies en 49 survival studies
In dit hoofdstuk werden de resultaten gepresenteerd van twee parallelle systematische reviews en 
meta-analyses naar de associatie tussen vroege proximale migratie van acetabulaire cups en late 
revisie. Een review omvatte vroege migratie waardes van RSA studies, terwijl de andere review 
revisie percentages aseptische loslating uit lange termijn survival studies betrof. Uitgaande van 
het verscheidene nationale implantaten registers waren revisie percentages van 5% op 10 jaar als 
standaard gekozen. Na de inclusie procedure bleven er 49 survival studies met totaal 38.013 cups 
over en 26 RSA studies met totaal 700 cups. Er was een significante associatie tussen proximale 
migratie en revisie percentage: voor elke millimeter proximale migratie nam het revisie percentage 
toe met 10%, hetgeen significant bleef na correctie voor leeftijd, geslacht, diagnose, type 
ziekenhuis, continent en studie kwaliteit. Dit leidde tot de volgende drempelwaardes. Proximale 
migratie van minder dan 0,2mm op 2 jaar was acceptabel. Een overschrijding van 1,0mm op 2 
jaar was onacceptabel. Als de migratie tussen de 0,2 en 1,0mm lag was het type prothese “at 
risk” voor revisie hoger dan de 5% 10-jaars revisiestandaard. Concluderend, met de voorgestelde 
migratie drempelwaardes was het mogelijk om onveilige cups vroeg te identificeren in een kleine 
groep patiënten. Cup surveillance met de drempelwaardes kan passen in een gefaseerde klinische 








































Nederlandse Samenvatting  |  177
N
Discussie and Conclusie
Via de “501(k) pathway” in de Verenigde Staten en via “notified bodies” in Europa (Directive 
93/42/EEC) worden nieuwe TKP en THP nu toegelaten op de vrije markt en verder gedistribueerd 
zonder uitgebreide veiligheid- en effectiviteitonderzoeken. 1,2 Deze gang van zaken heeft een 
reguleringsklimaat gecreëerd waarin onveilige TKP en THP op de markt kunnen komen. 3
De noodzaak van een gefaseerde klinische introductie voor nieuwe TKP en THP wordt steeds 
duidelijker. Zo’n gefaseerde klinische introductie bestaat al geruime tijd voor medicijnen en zou 
het mogelijk maken om de veiligheid en effectiviteit van nieuwe TKP en THP te monitoren om zo 
letsel aan patienten te voorkomen en kosten voor de maatschappij te beperken (anders gezegd 
de revisie last in de toekomst te reduceren). 
De studies van deze thesis laten zien dat onveilige (hoog revisie percentage voor loslating) TKP 
en THP met RSA studies kunnen worden geïdentificeerd in slechts 2 jaar follow-up. Vroege 
identificatie met RSA van deze onveilige TKP en THP voorkomt wijdverbreide gebruik. 
De gefaseerde klinische introductie van nieuwe implantaten op basis van RSA studies met 2 jaar 
follow-up kan leiden tot betere en veiligere patiëntzorg en tot een reductie van de kosten in 
de zorg ten gevolge van revisie van TKP en THP. Follow-up in nationale implantaten registers is 
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